Expandable spinal implant system and method of using same

Information

  • Patent Grant
  • 11806250
  • Patent Number
    11,806,250
  • Date Filed
    Monday, May 3, 2021
    2 years ago
  • Date Issued
    Tuesday, November 7, 2023
    5 months ago
Abstract
An expandable spinal implant is provided having first and second endplates hinged along one end and an expansion mechanism disposed therebetween configured to expand the first and second endplates from each other to provide a lordotic angle of up to 60 degrees. Various implants, systems and methods are disclosed.
Description
TECHNICAL FIELD

The present disclosure generally relates to medical devices for the treatment of musculoskeletal disorders, and more particularly to a surgical system that includes an expandable spinal implant, systems for implanting an expandable spinal implant, and a method for treating a spine.


BACKGROUND

Spinal disorders such as degenerative disc disease, disc herniation, osteoporosis, spondylolisthesis, stenosis, scoliosis and other curvature abnormalities, kyphosis, tumor, and fracture may result from factors including trauma, disease and degenerative conditions caused by injury and aging. Spinal disorders typically result in symptoms including pain, nerve damage, and partial or complete loss of mobility.


Non-surgical treatments, such as medication, rehabilitation and exercise can be effective, however, may fail to relieve the symptoms associated with these disorders. Surgical treatment of these spinal disorders includes fusion, fixation, correction, discectomy, laminectomy and implantable prosthetics. As part of these surgical treatments, spinal constructs, such as, for example, bone fasteners, spinal rods and interbody devices can be used to provide stability to a treated region. For example, during surgical treatment, interbody devices may be introduced to a space between adjacent vertebral bodies (the interbody space) to properly space the vertebral bodies and provide a receptacle for bone growth promoting materials.


More recently, interbody devices have been introduced that provide additional capability beyond static spacing of the vertebral bodies. For example, some devices have expansion capability such that the implant may be introduced to the interbody space in a collapsed state and then expanded to produce additional spacing and, in some cases, introduce or restore curvature to the spine by expanding selectively on only one end or portion of the implant. However, many existing expandable interbody designs have limited ranges of expansion.


An additional problem exists related to subsidence of spinal surfaces due to existing interbody devices having inadequately-sized load-bearing surfaces. In the case of expandable devices, the loads on the load-bearing surfaces, including loads generated during expansion of the implant, are often significant. An expandable implant with relatively large surface areas is needed to bear the loads, including the loads generated during implant expansion, in an attempt to avoid a need for follow-on surgery due to subsidence of spinal surfaces.


A further problem is instability of existing expandable interbody devices as they are expanded. Often, the load-bearing surfaces move relative to one another, as well as relative to an inserter, as the interbody device is expanded such that there is a risk of undesired shifts in the positioning of the interbody device within the interverterbral space.


The present invention seeks to address these and other shortcomings in the existing art.


SUMMARY

In one aspect, the present disclosure provides an expandable spinal implant deployable between a contracted position and an expanded position in a disc space between two vertebral bodies, the expandable spinal implant comprising a first endplate, the first endplate including an outer surface and an inner surface, a first endplate first end, a first endplate second end, a first endplate first lateral surface extending between the first endplate first end and the first endplate second end, an opposing first endplate second lateral surface extending between the first endplate first end and the first endplate second end; a second endplate, the second endplate including an outer surface and an inner surface, a second endplate first end, a second endplate second end, a second endplate first lateral surface extending between the second endplate first end and the second endplate second end, and an opposing second endplate second lateral surface extending between the second endplate first end and the second endplate second end, wherein the second endplate first end is pivotably engaged with the first endplate first end; an expansion mechanism disposed between the first endplate and the second endplate, the expansion mechanism including a wedge disposed between the first endplate and second endplate, the wedge including an upper surface, a lower surface, a wedge first end, a wedge second end, a wedge first lateral surface extending between the wedge first end and the wedge second end, and an opposing wedge second lateral surface extending between the wedge first end and the wedge second end, wherein the wedge comprises a wedge aperture between the wedge second end and wedge first end; a rod assembly, the rod assembly having a first end and a second end definining a longitudinal axis, wherein at least a portion of the rod assembly is disposed within the wedge aperture and operably engaged with the wedge to translate the wedge along the longitudinal axis of the rod; and wherein the wedge is operably engaged with at least one of the first endplate or second endplate and configured to expand the implant when the wedge is translated along the rod assembly in a first direction, and contract the implant when the wedge is translated along the rod assembly in a second direction.


In some embodiments, the rod assembly comprises a threaded outer surface, and the wedge aperture comprises a threaded inner surface operably engaged with the threaded outer surface of the rod.


In some embodiments, the translation of the wedge along the longitudinal axis of the rod in a first direction is towards the first and second endplate first ends. In some embodiments, translation of the wedge along the longitudinal axis of the rod in the first direction is towards the first and second endplate second ends.


In some embodiments, at least one of the first endplate or the second endplate further comprises at least one protrusion from its inner surface configured to engage a surface of the wedge. In some embodiments, at least one of the wedge first lateral surface and the wedge second lateral surface comprises a lateral post extending therefrom.


In some embodiments, at least one of the first endplate or second endplate further comprises at least one protrusion from its inner surface, wherein the at least one protrusion defines at least one lateral channel configured to receive the lateral post such that when the wedge is translated in the first direction, the lateral post of the wedge is moved in the first direction in the lateral channel to expand the implant and that when the wedge is translated in the second direction, the lateral post of the wedge is moved in the second direction in the lateral channel to contract the implant.


In some embodiments, the expandable spinal implant further comprises at least one vertebral endplate engagement component operably engaged to at least one of the first endplate or the second endplate and configured to engage with the wedge such that it protrudes from the outer surface of the first or second endplate when the wedge is translated in the first direction. In some embodiments, the vertebral endplate engagement component is configured to engage with the wedge such that it retracts from the outer surface of the first or second endplate when the wedge is translated in the second direction.


In some embodiments, the expandable spinal implant is capable of expanding up to 30 degrees, 35 degrees, 40 degrees, 45 degrees, 50 degrees, or 60 degrees or anywhere in between these amounts from 0 to 60 degrees.


In some embodiments, the expansion mechanism is secured to the second endplate. In some embodiments, the first end of the second endplate comprises a first aperture and the second end of the second endplate comprises a second aperture, and wherein the first end of the rod assembly is disposed within the first aperture and the second end of the rod assembly is disposed within the second aperture. In some embodiments, the rod assembly comprises a rod having a first and second end and a securing pin comprising a first and second end, the first end of the rod engaged with the second end of the securing pin, wherein the securing pin is disposed through the first aperture and the second end of the rod is diposed within the second aperture.


In some embodiments, the first endplate first end further comprises at least one protrusion comprising a lumen therethrough extending laterally along the first endplate first end; the second endplate first end further comprises at least one protusion comprising a lumen therethrough extending laterally along the second endplate first end; and the lumen through the at least one protrusion on the first endplate first end is co-axially aligned with the lumen through the at least one protrusion on the second endplate first end, and a rod is disposed through the lumens to pivotably engage first endplate first end with the second endplate first end.


In some embodiments, at least one of the first or second endplate comprises an aperture disposed therethrough from the outer surface to the inner surface, the aperture configured to receive an external screw for securing the first or second endplate to a vertebral body. In some embodiments, at least one of the first or second endplate comprises a tab extending from the first or second end, wherein the tab comprises an aperture therethrough configured to receive an external screw for securing first or second endplate to a vertebral body.


In some embodiments, at least one of the outer surfaces of the first or second endplates comprise anti-migration and/or anti-expulsion features. In some embodiments, at least one of the first or second endplates comprise apertures between the inner and outer surfaces thereof to allow bone growth material to be loaded into the implant. In some embodiments, at least one of the first or second endplates is porous.


In another aspect, the present disclosure provides an expandable spinal implant system comprising an insertion instrument comprising a drive cannula and a drive shaft removably and rotatably disposed within the drive cannula, and further comprising an attachment cannula and an attachment shaft removably and rotatably disposed within the attachment cannula; and an expandable spinal implant deployable between a contracted position and an expanded position in a disc space between two vertebral bodies, the expandable spinal implant comprising a first endplate, the first endplate including an outer surface and an inner surface, a first endplate first end, a first endplate second end, a first endplate first lateral surface extending between the first endplate first end and the first endplate second end, an opposing first endplate second lateral surface extending between the first endplate first end and the first endplate second end; a second endplate, the second endplate including an outer surface and an inner surface, a second endplate first end, a second endplate second end, a second endplate first lateral surface extending between the second endplate first end and the second endplate second end, and an opposing second endplate second lateral surface extending between the second endplate first end and the second endplate second end, wherein the second endplate first end is pivotably engaged with the first endplate first end; an expansion mechanism disposed between the first endplate and the second endplate, the expansion mechanism including a wedge disposed between the first endplate and second endplate, the wedge including an upper surface, a lower surface, a wedge first end, a wedge second end, a wedge first lateral surface extending between the wedge first end and the wedge second end, and an opposing wedge second lateral surface extending between the wedge first end and the wedge second end, wherein the wedge comprises a wedge aperture between the wedge second end and wedge first end; a rod assembly, the rod assembly having a first end and a second end defining a longitudinal axis, wherein at least a portion of the rod assembly is disposed within the wedge aperture and operably engaged with the wedge to translate the wedge along the longitudinal axis of the rod; and wherein the wedge is operably engaged with at least one of the first endplate or second endplate and configured to expand the implant when the wedge is translated along the rod assembly in a first direction, and contract the implant when the wedge is translated along the rod assembly in a second direction.


In another aspect, the present disclosure provides a method of deploying an expandable spinal implant in a disc space between two vertebral bodies, the method comprising utilizing an expandable spinal implant deployable between a contracted position and an expanded position in a disc space between upper and lower vertebral bodies, the expandable spinal implant comprising a first endplate, the first endplate including an outer surface and an inner surface, a first endplate first end, a first endplate second end, a first endplate first lateral surface extending between the first endplate first end and the first endplate second end, an opposing first endplate second lateral surface extending between the first endplate first end and the first endplate second end; a second endplate, the second endplate including an outer surface and an inner surface, a second endplate first end, a second endplate second end, a second endplate first lateral surface extending between the second endplate first end and the second endplate second end, and an opposing second endplate second lateral surface extending between the second endplate first end and the second endplate second end, wherein the second endplate first end is pivotably engaged with the first endplate first end; an expansion mechanism disposed between the first endplate and the second endplate, the expansion mechanism including a wedge disposed between the first endplate and second endplate, the wedge including an upper surface, a lower surface, a wedge first end, a wedge second end, a wedge first lateral surface extending between the wedge first end and the wedge second end, and an opposing wedge second lateral surface extending between the wedge first end and the wedge second end, wherein the wedge comprises a wedge aperture between the wedge second end and wedge first end; a rod assembly, the rod assembly having a first end and a second end defining a longitudinal axis, wherein at least a portion of the rod assembly is disposed within the wedge aperture and operably engaged with the wedge to translate the wedge along the longitudinal axis of the rod; and wherein the wedge is operably engaged with at least one of the first endplate or second endplate and configured to expand the implant when the wedge is translated along the rod assembly in a first direction, and contract the implant when the wedge is translated along the rod assembly in a second direction; inserting the implant in the collapsed position into the disc space between the upper and lower vertebral bodies; and expanding the first and second endplates.


In other aspects of the present disclosure, various other implants, systems and methods are disclosed.





BRIEF DESCRIPTION OF THE DRAWINGS

The present disclosure is further informed by the specific description accompanied by the following drawings, in which:



FIG. 1 is a perspective view of one embodiment of an expandable spinal implant in a closed configuration in accordance with the principles of the present disclosure;



FIG. 2 is a perspective view of one embodiment of an expandable spinal implant in an expanded configuration in accordance with the principles of the present disclosure;



FIG. 3 is a side view of one embodiment of an expandable spinal implant in a closed configuration in accordance with the principles of the present disclosure;



FIG. 4 is a side view of one embodiment of an expandable spinal implant in an expanded configuration in accordance with the principles of the present disclosure;



FIG. 5 is a side view of one embodiment of an expandable spinal implant in an expanded configuration in accordance with the principles of the present disclosure;



FIG. 6 is an exploded perspective view of one embodiment of an expandable spinal implant in an expanded configuration in accordance with the principles of the present disclosure;



FIG. 7 is an exploded perspective view of one embodiment of an expandable spinal implant in an expanded configuration in accordance with the principles of the present disclosure;



FIG. 8 is an exploded side view of one embodiment of an expandable spinal implant in an expanded configuration in accordance with the principles of the present disclosure;



FIG. 9 is an exploded end view of one embodiment of an expandable spinal implant in an expanded configuration in accordance with the principles of the present disclosure;



FIG. 10 is a perspective view of one embodiment of an expandable spinal implant in a closed configuration in accordance with the principles of the present disclosure;



FIG. 11 is a perspective view of the inner surface of one embodiment of an endplate in accordance with the principles of the present disclosure;



FIG. 12 is a perspective view of the outer surface of one embodiment of an endplate in accordance with the principles of the present disclosure;



FIG. 13 is a top cutaway view of one embodiment of an expandable spinal implant and inserter in accordance with the principles of the present disclosure;



FIG. 14 is a perspective view of one embodiment of an expandable spinal implant in a closed configuration in accordance with the principles of the present disclosure;



FIG. 15 is a perspective view of one embodiment of an expandable spinal implant in an expanded configuration in accordance with the principles of the present disclosure;



FIG. 16 is a side view of one embodiment of an expandable spinal implant in a closed configuration in accordance with the principles of the present disclosure;



FIG. 17 is a side view of one embodiment of an expandable spinal implant in an expanded configuration in accordance with the principles of the present disclosure;



FIG. 18 is a perspective view of one embodiment of an expandable spinal implant in an expanded configuration in accordance with the principles of the present disclosure;



FIG. 19 is a perspective view of one embodiment of an expandable spinal implant in an expanded configuration in accordance with the principles of the present disclosure;



FIG. 20A is a perspective view and FIG. 20B is a plane view of the outer surface of one embodiment of an endplate in accordance with the principles of the present disclosure;



FIG. 21A is a perspective view and FIG. 21B is a plane view of the outer surface of one embodiment of an endplate in accordance with the principles of the present disclosure;



FIG. 22A is a perspective view and FIG. 22B is a plane view of the outer surface of one embodiment of an endplate in accordance with the principles of the present disclosure;



FIG. 23A is a perspective view and FIG. 23B is a plane view of the outer surface of one embodiment of an endplate in accordance with the principles of the present disclosure;



FIG. 24A depicts one embodiment of an expandable spinal implant and inserter in a first position in accordance with the principles of the present disclosure;



FIG. 24B depicts one embodiment of an expandable spinal implant and inserter in a second position in accordance with the principles of the present disclosure;



FIG. 24C depicts one embodiment of an expandable spinal implant and inserter in a third position in accordance with the principles of the present disclosure;



FIG. 25 is a top view of one embodiment of an expandable spinal implant as used in a spinal procedure in accordance with the principles of the present disclosure;



FIG. 26 is a top view of one embodiment of an expandable spinal implant as used in a spinal procedure in accordance with the principles of the present disclosure;



FIG. 27 is a side view of one embodiment of an expandable spinal implant in a closed configuration in accordance with the principles of the present disclosure;



FIG. 28 is a side view of one embodiment of an expandable spinal implant in an expanded configuration in accordance with the principles of the present disclosure;



FIG. 29 is a cutaway side view of one embodiment of an expandable spinal implant in a closed configuration in accordance with the principles of the present disclosure;



FIG. 30 is a perspective view of one embodiment of an expandable spinal implant in a partially expanded configuration in accordance with the principles of the present disclosure;



FIG. 31A is a perspective view and FIG. 31B is a plane view of the outer surface of one embodiment of an endplate in accordance with the principles of the present disclosure;



FIG. 32A is a perspective view and FIG. 32B is a plane view of the outer surface of one embodiment of an endplate in accordance with the principles of the present disclosure;



FIG. 33A is a perspective view and FIG. 33B is a plane view of the outer surface of one embodiment of an endplate in accordance with the principles of the present disclosure;



FIG. 34A is a perspective view and FIG. 34B is a plane view of the outer surface of one embodiment of an endplate in accordance with the principles of the present disclosure;



FIG. 35 is an end view of one embodiment of an expansion mechanism wedge in accordance with the principles of the present disclosure;



FIG. 36 is a top view of one embodiment of an endplate in accordance with the principles of the present disclosure;



FIG. 37 is a side view of one embodiment of an expandable spinal implant as used in a spinal procedure in accordance with the principles of the present disclosure;



FIG. 38 is a side view of one embodiment of an expandable spinal implant as used in a spinal procedure in accordance with the principles of the present disclosure;



FIG. 39 is a side view of one embodiment of an expandable spinal implant as used in a spinal procedure in accordance with the principles of the present disclosure.





Common numbering schemes in FIGS. 1-39 (e.g., 1xx, 2xx and 3xx), indicate similar components of implants 10, 20, and 30.


DETAILED DESCRIPTION

The exemplary embodiments of the surgical system and related methods of use disclosed are discussed in terms of medical devices for the treatment of musculoskeletal disorders and more particularly, in terms of an expandable surgical implant system that may include an expandable spinal implant, an insertion instrument, specialized instruments such as, for example, an expandable retractor and a spinal surgical table that rotates and bends the patient in various directions, and/or a method or methods for treating a spine.


In some embodiments, the present system includes an expandable spinal implant suitable for insertion from an oblique, postero-lateral procedures and/or transforaminal lumbar interbody fusions (sometimes referred to as TLIF procedures), direct posterior (sometimes referred to as PLIF procedures), direct lateral (sometimes referred to as DLIF procedures), anterior lumbar interbody fusions (sometimes refered to as ALIF procedures), or variations of these procedures, in which the present implant is inserted into an interverterbral space and then expanded in order to impart and/or augment a lordotic and/or kyphotic curve of the spine.


In some embodiments, the spinal implant system may also be employed to restore and/or impart sagittal balance to a patient by increasing and/or restoring an appropriate lordotic and/or kyphotic angle between vertebral bodies at a selected level where the spinal implant is implanted and expanded. In the various embodiments described, the spinal implant system may be useful in a variety of complex spinal procedures for treating spinal conditions beyond one-level fusions. Furthermore, the spinal implant system described in the enclosed embodiments may also be used as a fusion device with an expandable height for tailoring the implant to a particular interbody disc space to restore the spacing between adjacent vertebral bodies and facilitate spinal fusion between the adjacent vertebral bodies.


In some embodiments, and as mentioned above, the present disclosure may be employed to treat spinal disorders such as, for example, degenerative disc disease, disc herniation, osteoporosis, spondylolisthesis, stenosis, scoliosis and other curvature abnormalities, kyphosis, tumor and fractures. In some embodiments, the present disclosure may be employed with other osteal and bone related applications, including those associated with diagnostics and therapeutics. In some embodiments, the disclosed spinal implant system may be alternatively employed in a surgical treatment with a patient in a prone or supine position, and/or employ various surgical approaches to the spine, including anterior, posterior, posterior mid-line, direct lateral, postero-lateral oblique, and/or antero lateral oblique approaches, and in other body regions. The present disclosure may also be alternatively employed with procedures for treating the lumbar, cervical, thoracic, sacral and pelvic regions of a spinal column. The spinal implant system of the present disclosure may also be used on animals, bone models and other non-living substrates, such as, for example, in training, testing and demonstration.


The present disclosure may be understood more readily by reference to the following detailed description of the embodiments taken in connection with the accompanying drawing figures, which form a part of this disclosure. It is to be understood that this application is not limited to the specific devices, methods, conditions or parameters described and/or shown herein, and that the terminology used herein is for the purpose of describing particular embodiments by way of example only and is not intended to be limiting. In some embodiments, as used in the specification and including the appended claims, the singular forms “a,” “an,” and “the” include the plural, and reference to a particular numerical value includes at least that particular value, unless the context clearly dictates otherwise. Ranges may be expressed herein as from “about” or “approximately” one particular value and/or to “about” or “approximately” another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another embodiment. It is also understood that all spatial references, such as, for example, horizontal, vertical, top, upper, lower, bottom, left and right, are for illustrative purposes only and can be varied within the scope of the disclosure. For example, the references “upper” and “lower” are relative and used only in the context to the other, and are not necessarily “superior” and “inferior”. Generally, similar spatial references of different aspects or components, e.g., a “first end” of an end plate and a “first end” of a wedge, indicate similar spatial orientation and/or positioning, i.e., that each “first end” is situated on or directed towards the same end of the device. Further, the use of various spatial terminology herein should not be interpreted to limit the various insertion techniques or orientations of the implant relative to the positions in the spine.


As used in the specification and including the appended claims, “treating” or “treatment” of a disease or condition refers to performing a procedure that may include administering one or more drugs, biologics, bone grafts (including allograft, autograft, xenograft, for example) or bone-growth promoting materials to a patient (human, normal or otherwise or other mammal), employing implantable devices, and/or employing instruments that treat the disease, such as, for example, micro-discectomy instruments used to remove portions bulging or herniated discs and/or bone spurs, in an effort to alleviate signs or symptoms of the disease or condition. Alleviation can occur prior to signs or symptoms of the disease or condition appearing, as well as after their appearance. Thus, treating or treatment includes preventing or prevention of disease or undesirable condition (e.g., preventing the disease from occurring in a patient, who may be predisposed to the disease but has not yet been diagnosed as having it). In addition, treating or treatment does not require complete alleviation of signs or symptoms, does not require a cure, and specifically includes procedures that have only a marginal effect on the patient. Treatment can include inhibiting the disease, e.g., arresting its development, or relieving the disease, e.g., causing regression of the disease. For example, treatment can include reducing acute or chronic inflammation; alleviating pain and mitigating and inducing re-growth of new ligament, bone and other tissues; as an adjunct in surgery; and/or any repair procedure. Also, as used in the specification and including the appended claims, the term “tissue” includes soft tissue, ligaments, tendons, cartilage and/or bone unless specifically referred to otherwise. The term “bone growth promoting material” as used herein may include, but is not limited to: bone graft (autograft, allograft, xenograft) in a variety of forms and compositions (including but not limited to morselized bone graft); osteoinductive material such as bone morphogenetic proteins (BMP) (including but not limited to INFUSE® available from Medtronic) and alternative small molecule osteoinductive substances; osteoconductive materials such as demineralized bone matrix (DBM) in a variety of forms and compositions (putty, chips, bagged (including but not limited to the GRAFTON® family of products available from Medtronic)); collagen sponge; bone putty; ceramic-based void fillers; ceramic powders; and/or other substances suitable for inducing, conducting or facilitating bone growth and/or bony fusion of existing bony structures. Such bone growth promoting materials may be provided in a variety of solids, putties, liquids, colloids, solutions, or other preparations suitable for being packed or placed into or around the various implant 10, 20, 30 embodiments described herein.


The following discussion includes a description of a surgical system including one or more spinal implants, related components and methods of employing the surgical system in accordance with the principles of the present disclosure. Various alternate embodiments are disclosed and individual components of each embodiment may be used with other embodiments. Reference is made in detail to the exemplary embodiments of the present disclosure, which are illustrated in the accompanying figures. Turning to FIGS. 1-36, there are illustrated components of a surgical system, such as, for example, an expandable spinal implant 10, 20, and 30.


The components of the expandable spinal implant systems described herein can be fabricated from biologically acceptable materials suitable for medical applications, including metals, synthetic polymers, ceramics and bone material and/or their composites. For example, the components of expandable spinal implant system, individually or collectively, can be fabricated from materials such as stainless steel alloys, commercially pure titanium, titanium alloys, Grade 5 titanium, super-elastic titanium alloys, cobalt-chrome alloys, stainless steel alloys, superelastic metallic alloys (e.g., Nitinol, super elasto-plastic metals, such as GUM METAL®), ceramics and composites thereof such as calcium phosphate (e.g., SKELITE™), thermoplastics such as polyaryletherketone (PAEK) including polyetheretherketone (PEEK), polyetherketoneketone (PEKK) and polyetherketone (PEK), carbon-PEEK composites, PEEK-BaSO4 polymeric rubbers, polyethylene terephthalate (PET), fabric, silicone, polyurethane, silicone-polyurethane copolymers, polymeric rubbers, polyolefin rubbers, hydrogels, semi-rigid and rigid materials, elastomers, rubbers, thermoplastic elastomers, thermoset elastomers, elastomeric composites, rigid polymers including polyphenylene, polyamide, polyimide, polyetherimide, polyethylene, epoxy, bone material including autograft, allograft, xenograft or transgenic cortical and/or corticocancellous bone, and tissue growth or differentiation factors, partially resorbable materials, such as, for example, composites of metals and calcium-based ceramics, composites of PEEK and calcium based ceramics, composites of PEEK with resorbable polymers, totally resorbable materials, such as, for example, calcium based ceramics such as calcium phosphate, tri-calcium phosphate (TCP), hydroxyapatite (HA)-TCP, calcium sulfate, or other resorbable polymers such as polyaetide, polyglycolide, polytyrosine carbonate, polycaprolactone and their combinations.


Various components of spinal implant system may be formed or constructed of material composites, including but not limited to the above-described materials, to achieve various desired characteristics such as strength, rigidity, elasticity, compliance, biomechanical performance, durability and radiolucency or imaging preference. The components of expandable spinal implant system, individually or collectively, may also be fabricated from a heterogeneous material such as a combination of two or more of the above-described materials. The components of the expandable spinal implant systems may be monolithically formed, integrally connected or include fastening elements and/or instruments, as described herein. For example, in some embodiments the expandable spinal implant systems may comprise expandable spinal implants 10, 20, 30 comprising PEEK and/or titanium structures with radiolucent markers (such as tantalum pins and/or spikes) selectively placed in the implant to provide a medical practitioner with placement and/or sizing information when the expandable spinal implant 10, 20, 30 is placed in the spine. The components of the expandable spinal implant system may be formed using a variety of subtractive and additive manufacturing techniques, including, but not limited to machining, milling, extruding, molding, 3D-printing, sintering, coating, vapor deposition, and laser/beam melting. Furthermore, various components of the expandable spinal implant system may be coated or treated with a variety of additives or coatings to improve biocompatibility, bone growth promotion or other features. For example, the endplates 110, 120, 210, 220, 310, 320 may be selectively coated with bone growth promoting or bone ongrowth promoting surface treatments that may include, but are not limited to: titanium coatings (solid, porous or textured), hydroxyapatite coatings, or titanium plates (solid, porous or textured).


The expandable spinal implant system may be employed, for example, with a minimally invasive procedure, including percutaneous techniques, mini-open and open surgical techniques to deliver and introduce instrumentation and/or one or more spinal implants at a surgical site within a body of a patient, for example, a section of a spine. In some embodiments, the expandable spinal implant system may be employed with surgical procedures, as described herein, and/or, for example, corpectomy, discectomy, fusion and/or fixation treatments that employ spinal implants to restore the mechanical support function of vertebrae. In some embodiments, the expandable spinal implant system may be employed with surgical approaches, including but not limited to: anterior lumbar interbody fusions (ALIF), posterior lumbar interbody fusion (PLIF), oblique lumbar interbody fusion, transforaminal lumbar interbody fusion (TLIF), various types of anterior fusion procedures, and any fusion procedure in any portion of the spinal column (sacral, lumbar, thoracic, and cervical, for example).


Generally in FIGS. 1-36, three exemplary embodiments of an expandable spinal implant 10, 20, and 30 are shown (implant 10 is highlighted in exemplary FIGS. 1-13, implant 20 is highlighted in exemplary FIGS. 14-26, and implant 30 is highlighted in exemplary FIGS. 27-36). Expandable spinal implants 10, 20, and 30 may comprise first and second endplates operably engaged via a hinge mechanism that lordotically or angularly expands the endplates relative to one another via a wedge mechanism driven perpendicularly to the axis of the hinge joint. In some embodiments, the wedge drive direction may be oriented at an oblique angle between 0 and 90 degrees to the hinge axis. In some embodiments, the first and second endplates may lordotically expand when the wedge mechanism is driven towards the hinge. In other embodiments, the first and second endplates may lordotically expand when the wedge mechanism is driven away from the hinge.


As shown in FIGS. 1-13, an expandable spinal implant 10 is configured to be inserted in an intervertebral disc space between adjacent vertebral bodies. The implant 10 includes a first end 12 and a second end 14 defining a mid-longitudinal axis L1-L1 therebetween. In some embodiments, the expandable spinal implant 10 comprises a first endplate 110 and second endplate 120. First endplate 110 includes a first end 112, a second end 114, two opposing side surfaces 115 extending from the first end 112 of the first endplate to a portion of the second end 114 of the first endplate, and with the first endplate being therebetween, an inner surface 116, and an outer surface 118. Second endplate 120 includes a first end 122, a second end 124, two opposing side surfaces 125 extending from the first end 122 of the second endplate to a portion of the second end 124 of the second endplate, and with the second endplate being therebetween, an inner surface 126, and an outer surface 128. In one embodiment, endplates 110, 120 include projections 111, 121 configured to engage a surface of an endplate of an adjacent vertebral body (not shown). Projections 111, 121 may comprise various anti-migration, anti-expulsion, and/or osseointegration features including, but not limited to: ridges, teeth, pores, and coatings (including but not limited to porous titanium coatings such as those provided on Capstone PTC™ implants available from Medtronic). The endplates 110, 120 may further comprise at least one opening 113, 123 defined therein, configured to allow bone growth materials to be packed, placed, or loaded into implant 10.


Referring generally to FIGS. 1-12, endplates 110, 120 may be operably engaged via a hinge mechanism located near or on first ends 112 and 122. For example, as shown in FIG. 7, first end 112 of first endplate 110 may comprise first and second hinge protrusions 117 extending along at least a portion of the length of first end 112 perpendicular to mid-longitudinal axis L1-L1. In some embodiments, first and second hinge protrusions are cylindrical and extend from lateral side surfaces 115 towards the mid-longitudinal axis L1-L1, and further comprise lumen 117b extending therethrough. First end 122 of second endplate 120 may also comprise a hinge protrusion 127. In some embodiments, hinge protrusion 127 is cylindrical and extends laterally along first end 122, and further comprises a lumen 127b extending therethrough. The lumen of first and second hinge protrusions 117 and lumen of hinge protrusion 127 may be co-axially aligned along a hinge axis H1-H1. A pin 130 may be disposed within the lumen of hinge protrusions 117, 127 to pivotably engage first endplate 110 to second endplate 120. In this way, first endplate 110 may hinge and/or rotate away from second endplate 120 such that the distance between second ends 114 and 124 is increased along radial arc R. While a simple pin and lumen hinge is shown in some of the pictured embodiments, it should be understood that other types of hinge and/or connection mechanisms may also be used to operably engage the endplates 110, 120 of the implant. For example, in some embodiments, a “living hinge” may be utilized wherein the endplates 110, 120 are at least partially integrally formed at the hinge point but with cut-outs or flex points that allow the endplates 110, 120 to rotate about the hinge connection. Endplates 110, 120 may be operably engaged in a number of different ways including but not limited to: integral connections, separable connections, mechanically fixed connections using fastener or adhesives, releasable connections (including, but not limited to keyways and partially open hinges), and other connection types. In some embodiments, endplates 110, 120 may be integrally formed using additive manufacturing techniques such as 3D printing, sintering laser/beam melting, casting, extruding, or machined in an integral form using subtractive manufacturing techniques from one or more stock materials.


As described herein, the implant 10 may include an expansion mechanism for expanding endplates 110, 120 to increase the lordotic angle R of implant 10. In some embodiments, the expansion mechanism of implant 10 includes a rod assembly 140 having a longitudinal axis E3-E3 comprising a rod 142, a securing pin 143 and wedge 150 mounted within the implant between first endplate 110 and second endplate 120. Wedge 150 may comprise a first end 152, a second end 154, an upper surface 158, a lower surface 156, and opposing lateral surfaces 155 extending between the first and second ends. Wedge 150 may further comprise an aperture 151 between the first and second ends. Rod assembly 140 may comprise rod 142 disposed within aperture 151. In some embodiments, rod 142 comprises a threaded outer surface 141 configured to be engaged with a complimentary inner threaded surface of aperture 151 of wedge 150 such that the wedge 150 travels forward and backwards along rod 142 between first and second ends of implant 10 when rod 142 is rotated relative to wedge 150. In some embodiments, rod 142 and securing pin 143 may be integrally formed, and in such embodiments, it will be understood that integral rod assembly 140 may be interchanged with rod 142 in the discussions below.


The expansion mechanism of implant 10 may be operably engaged with first or second endplates 110, 120. In some embodiments, the expansion mechanism of implant 10 is secured to second endplate 120. Hinge protrusion 127 of second endplate 120 may comprise a first end aperture 127a through the walls of hinge protrusion 127 and generally perpendicular to lumen 127b therethrough. Second end 124 of second endplate 120 may further comprise an aperture 124a therethrough. In some embodiments, apertures 127a and 124a are generally co-axial. One or both ends of rod assembly 140 may be secured within one or both of aperture 124a of second end 124 and first aperture 127a of hinge protrusion 127 along first end 122 to operably engage the expansion mechanism of implant 10 with second endplate 120. In the embodiment shown, second end of rod 142 is secured within aperture 124a, and a cylindrical securing pin 143 disposed through aperture 127a coaxially engages an end of rod 142 to further secure the expansion mechanism within implant 10. Pin 130 disposed within the lumen of hinge protrusions 117, 127 may include a cut out portion 131 to allow rod 142 and/or cylindrical securing pin 143 to be disposed through aperture 127a. In some embodiments, rod assembly 140 is disposed such that longitudinal axis E1-E1 is substantially parallel to mid-longitudinal axis L1-L1 of implant 10 (i.e., perpendicular to hinge axis H1-H1). In some embodiments, apertures 124a and 127a may be aligned such that rod assembly 140 is disposed such that longitudinal axis E1-E1 is at an oblique angle to the mid-longitudinal axis L1-L1 of implant 10 (e.g., between zero and 90 degrees).


Rod 142 may be rotatable within apertures 124a, 127a relative to implant 10. Inner surface 116 of first endplate 110 may comprise guidewalls 116a extending away from the inner surface 116 of first endplate 110. In some embodiments, guidewalls 116a extend perpendicularly away from inner surface 116 of first endplate 110. In some embodiments, guidewalls 116a are oriented substantially parallel to the longitudinal axis L of rod 142 and are disposed a width W apart from one another. In some embodiments, the width W is substantially similar to the width of wedge 150, with wedge 150 being disposed between guidewalls 116a. Lateral sides 155 of wedge 150 engage with guidewalls 116a such that rotation of wedge 150 relative to implant 10 is prevented. In this way, the interaction between threaded surfaces 141, 151 cause wedge 150 to translate along longitudinal axis L of rod 142 when rod 142 is rotated.


Wedge 150 may include an upper surface 158 configured to engage with inner surface 116 of first endplate 110 and lordotically expand first endplate 110 away from second endplate 120 when wedge 150 is moved towards first end 12 of implant 10. For example, upper surface 158 may be ramped or wedge-shaped and suitable for urging a complementary ramped or contoured surface on the inside of first endplate 110 so as to gradually move first endplate 140 away from second endplate 150 as wedge 150 is advanced towards first end 12 along rod 142. In the embodiment depicted, inner surface 116 of first endplate 110 may further comprise ramps 116b to engage upper surface 158 of wedge 150. In some embodiments, the expansion mechanism may be configured such that lower surface 156 of wedge 150 engages inner surface 126 of second endplate 120 alternatively to, or in addition to, upper surface 158 engaging inner surface 116 of first endplate 110. In some embodiment, the expansion mechanism may be configured to lordotically expand implant 10 when wedge 150 is moved towards the second end 14 of implant 10.


In some embodiments, the ramp mechanism 158/116b may cooperate with one or more paired lateral posts 155a and channel 116c system in order to optimize the opening and/or expansion of implant 10. Guidewalls 116a may comprise lateral channels 116c. Channels 116c may be angled or partially angled to provide a mechanism for assisting in the expansion of implant 10 as wedge 150 is advanced along rod 142 towards the hinge at first end 12 of implant 10. Wedge 150 may comprise one or more lateral posts 155a that engage with channels 116c to provide an expansion mechanism configured to urge first endplate 110 away from second endplate 120 when wedge 150 is moved towards first end 12 of implant 10. Post 155a and channel 116c mechanism may also aid in making expansion of the implant 10 substantially reversible such that when wedge 150 is moved away from the hinge, lateral posts 155a are moved in a second direction in the lateral channels 116c to contract first endplate 110 towards second endplate 120 (which may result in implant 10 returning to the closed or unexpanded configuration shown generally in FIG. 1). This reversible feature, combined with the threaded interaction between rod 142 and wedge 150, renders implant 10 capable of being incrementally expanded or contracted through a substantially infinite adjustable range of motion (bounded only by the length of the channels 116c). The length and orientation of channels 116c may be adjusted to determine the amount of lordotic expansion. In some embodiments, the design of the expansion mechanism, including the length and orientation of channels 116c, is configured to allow up to 30 degrees, 35 degrees, 40 degrees, 45 degrees, 50 degrees, or 60 degrees or anywhere in between these amounts from 0 to 60 degrees or more of lordotic expansion as wedge 150 is moved towards the hinge assembly.


In some embodiments, various designs may be used to optimize the interaction of wedge 150 with first endplate 110. Such configurations may include, but are not limited to: sequential ramps or tapered surfaces with varying angles; shallow angle sequential ramps or tapered surfaces leading into higher angle sequential ramps or tapered surfaces, as well as other opening mechanisms (such as the lateral post 155a and channel 116c system described above that may combine to assist the ramps in expanding implant 10).


As described above, the expansion mechanism 140, 150 of implant 10 is secured to second endplate 120 such that first endplate 110 is urged away from expansion mechanism 140, 150 and second endplate 120 when wedge 150 is moved towards first end 12 of implant 10. In some embodiments, only a first end 145 of rod assembly 140 may be secured to first and/or second endplates 110, 120 such that the a second end 146 of rod assembly 140 may move relative to endplates 110, 120 as implant 10 is expanded or contracted. In such embodiments, lower surface 156 of wedge 150 may be ramped or wedge-shaped and suitable for urging a complementary ramped or contoured surface on the inside of second endplate 120 so as to gradually move the endplates 110, 120 away from each other as the wedge 150 is advanced along the rod 142. Inner surface 126 of second endplate 120 comprise ramps to engage lower surface 156 of wedge 150, and/or may comprise guidewalls with channels disposed therein to engage lateral posts extending from wedge 150, similar to those described above for the interaction of upper surface 158 of wedge 150 with inner surface 116 of first endplate 110. In some embodiments, various designs may be used to optimize the interaction of wedge 150 with endplates 110, 120. Such configurations may include, but are not limited to: sequential ramps or tapered surfaces with varying angles; shallow angle sequential ramps or tapered surfaces leading into higher angle sequential ramps or tapered surfaces, as well as other opening mechanisms (such as the lateral post 155a and channel 116c system described above that may combine to assist the ramps in expanding the implant 10).


As wedge 150 moves towards the hinge, the mechanism loses mechanical advantage because the lever arm between the wedge and hinge joint decreases during expansion. This provides increased force feedback to a medical practitioner using implant 10, giving the medical practitioner a better feel of anatomical constraints. To supplement the expansion force, implant 10 may be specifically paired or used with other surgical instruments that manipulate the spine. These surgical instruments include, for example, surgical tables, patient positioning frames, and the like, that manipulate the patient and may for example further facilitate and/or adjust access to one or more disc spaces by bending the spine of a patient in various directions and adjusting the orientation of the patient to ease or facilitate access to the spinal surgical location(s). Exemplary surgical tables, patient positioning frames, and the like, and related methods of using them include those described in, e.g., U.S. patent application Ser. Nos. 15/239,239, 15/239,256, 15/337,157, 15/638,802, 15/639,080, 15/672,005, and 15/674,456, all incorporated herein by reference in their entirety.


In some embodiments, second end 146 of rod 142 may comprise an interface 144 configured to be operably engaged by a drive shaft (not shown) to rotate rod 142. Rod interface 144 may comprise a drive receptacle configured to cooperate with an implant-engaging end of the drive shaft. The drive connection between the driver shaft and rod interface 144 may comprise a variety of drive interfaces including but not limited to: multi-lobular drives; hexalobular drives; cross or Phillips head drives; straight or “flat head” drives; square or other polygonal drives; and/or combinations thereof. In other embodiments, first end 145 of rod assembly 140 (via rod 142 or securing pin 143) may further comprise an interface configured to be operably engaged by a drive shaft to rotate rod assembly 140. In this way, implants of the present disclosure may be expanded from both an anterior/oblique and posterior approach.


In some embodiments, implant 10 may further comprise vertebral endplate engagement components 170 which are configured to engage the vertebral endplate as the implant 10 is expanding. In some embodiments, vertebral endplate engagement components 170 may be claw- or hook-shaped. It is contemplated that vertebral endplate engagement components 170 may comprise various configurations suitable to engage the vertebral endplate to decrease or prevent potential migration or expulsion of the device from the intervertebral space. As shown in FIGS. 1 and 3, when implant 10 is in a collapsed, closed, or unexpanded state, vertebral endplate engagement components 170 may be retracted within the device to allow for easy insertion into the disc space. As shown in FIGS. 2 and 4, as implant 10 is expanded, and vertebral endplate engagement components 170 protrude from implant 10 and engage the vertebral endplate to decrease potential migration of the device. In the embodiment depicted in FIGS. 1-12, the vertebral endplate engagement components 170 are mounted between guidewalls 116a and disposed adjacent upper surface 158 of wedge 150. Guidewalls 116a may each comprise an aperture 171 through which a pin 172 is disposed to mount vertebral endplate engagement components 170 to first endplate 110. In some embodiments, vertebral endplate engagement components 170 are at least partially rotatable about pin 172. Vertebral endplate engagement components 170 may be shaped to engage upper surface 158 of wedge 150 as wedge 150 is moved towards first end 12 of implant 10, causing the teeth 170 to partially rotate about pin 172 and protrude through apertures 119 of first endplate 110 and engage the vertebral endplate. As wedge 150 is moved away from first end 12, a separate portion of vertebral endplate engagement components 170 may engage upper surface 158 of wedge 150 to retract vertebral endplate engagement components 170 back into the interior of implant 10. In an alternative embodiment (not shown), vertebral endplate engagement components 170 could be incorporated into a piston. Wedge 150 would engage the piston as implant 10 is expanded. In another embodiment (not shown), vertebral endplate engagement components 170 could be mounted onto a rotating gear. A mating gear on wedge 150 would engage the rotating gear and rotate vertebral endplate engagement components 170 into engagement with the vertebral endplate as the wedge 150 expands implant 10. In another embodiment (not shown), rod assembly 140 may engage vertebral endplate engagement components 170 directly, via, e.g., threaded outer surface 141.


Although FIGS. 1-12 depict vertebral endplate engagement components 170 protruding only from first endplate 110, other embodiments may include vertebral endplate engagement components protruding from second endplate 120, or from both endplates 110, 120. In some embodiments, implant 10 may be secured through intrinsic screws placed through apertures between inner and outer surfaces of endplates 110 or 120 (as depicted for implant 20 in FIGS. 18, 19 and discussed below). These screws may be further held in place by external locking mechanisms such as washers, springs, plates or covers that cover or push against at least a portion of the screw top or head. In other embodiments the screws may be held in place by interference fit in the screw hole and/or by features in the screw hole adding friction fit and/or holding force to the screw top or head. In other embodiments, implant 10 may be secured through integrated tabs on endplates 110 or 120 (as depicted for implant 30 in FIG. 30 and as discussed below) or separable plates that may cover a portion of the intervertebral implant.



FIG. 13 shows an implant 10 in use with an insertion instrument 40 to form an expandable spinal implant system according to one embodiment. As shown generally in FIG. 13, the system may comprise an insertion instrument 40 comprising an attachment cannula 410 and a driver cannula 420. Insertion instrument 40 may further comprise an attachment shaft 411 removably and rotatably disposed within attachment cannula 410 and a drive shaft 421 removably and rotatably disposed within driver cannula 420. The implant engaging end of attachment shaft 411 may comprise a threaded outer surface. Insertion instrument 40 may further comprise a drive engagement component 422 connected to the end of drive shaft 421 via, for example, a u-joint 423.


The system may also further comprise an expandable spinal implant 10 configured to be operably engaged with the insertion instrument 40 using a variety of mechanisms. As described herein, second end 14 of implant 10 may be configured to receive the tool end of insertion instrument 40 to manipulate expandable implant 10. In one embodiment, second end 124 of second endplate 120 of implant 10 comprises attachment apertures 124b disposed laterally adjacent to aperture 124a. These apertures 124b may be spaced and angled relative to mid-longitudinal axis L1-L1 of implant 10 as desired for particular surgical techniques. In some embodiments, apertures 124b may be parallel to mid-longitudinal axis L1-L1 of implant 10. In the depicted embodiment, the axis of apertures 124b is angled at approximately 15 degrees relative to mid-longitudinal axis L1-L1. Apertures 124b may comprise an inner threaded surface for engaging the threaded outer surface on the implant engaging end of attachment shaft 411. In other embodiments, the implant engaging end of attachment shaft 411 may interact with tabs or slots defined by one or both of endplates 110, 120. The attachment shaft 411 may be coaxially placed within the attachment cannula 410 and rotatable therein using the manual end of the attachment cannula (not shown). The manual end of the attachment shaft 411 may comprise a keyed or faceted surface configured for engagement with a quick-release handle (not shown) or a powered driver (not shown) for rotating attachment shaft 411.


In some embodiments, as shown in FIG. 13, interface 144 of rod 142 may be configured to be operably engaged by an implant engaging end of drive shaft 421 to translate (by threaded rotation, for example) wedge 150 along rod 142. Drive shaft 421 may be coaxially placed within drive cannula 420 and rotatable therein using the manual end of drive shaft 421 (not shown). The manual end of drive shaft 421 may comprise a keyed or faceted surface configured for engagement with a quick-release handle (not shown) or a powered driver (not shown) for rotating the drive shaft 421. Furthermore, rod interface 144 may comprise a drive receptacle configured to cooperate with an implant engaging end of drive shaft 421. The drive connection between drive shaft 421 and rod interface 144 may comprise a variety of drive interfaces including but not limited to: multi-lobular drives; hexalobular drives; cross or Phillips head drives; straight or “flat head” drives; square or other polygonal drives; and/or combinations thereof. In some embodiments, drive shaft 421 engages rod interface 144 via a drive engagement component 422 connected to the end of drive shaft 421 via, for example, a u-joint 423. U-joint 423 allows for angulation between the drive shaft 421 and rod assembly 140.



FIGS. 14-26 show various configurations of an implant 20 embodiment according to the present disclosure. Implant 20 is generally similar in construction to implant 10 described above and implant 30 described below, and comprises a first endplate 210 and second endplate 220 operably engaged to one another via a hinge mechanism along an implant first end 22, and an expansion mechanism comprising a rod assembly 240 and a wedge 250 disposed therebetween. First endplate 210 includes a first end 212, a second end 214, opposing side surfaces 215 extending from the first end 212 of the first endplate to a portion of the second end 214 of the first endplate, and with the first endplate being therebetween, an inner surface 216, and an outer surface 218. Second endplate 220 includes a first end 222, a second end 224, two opposing side surfaces 225 extending from the first end 222 of the second endplate to a portion of the second end 224 of the second endplate, and with the second endplate being therebetween, an inner surface 226, and an outer surface 228. In one embodiment, the endplates 210, 220 includes projections 211, 221 configured to engage a surface of the endplate of the adjacent vertebral body (not shown). Projections 211, 221 may comprise various anti-migration, anti-expulsion, and/or osseointegration features including, but not limited to: ridges, teeth, pores, and coatings (including but not limited to porous titanium coatings such as those provided on Capstone PTC™ implants available from Medtronic). Endplates 210, 220 may further comprise at least one opening 213, 223 defined therein, configured to allow bone growth materials to be packed, placed, or loaded into implant 20.


The endplates 210, 220 may be operably engaged via a hinge mechanism located near or on the first ends 212 and 222. For example, first end 212 of first endplate 210 may comprise first and second hinge protrusions 217 extending along at least a portion of the length of first end 212 perpendicular to mid-longitudinal axis L2-L2. In some embodiments, first and second hinge protrusions are cylindrical and extend from lateral side surfaces 215 towards the mid-longitudinal axis L2-L2, and further comprise lumen 217b extending therethrough. First end 222 of second endplate 220 may also comprise a hinge protrusion 227. In some embodiments, hinge protrusion 227 is cylindrical and extends laterally along first end 122, and further comprises a lumen 227b extending therethrough. Lumens 217b, 227b of hinge protrusions 217, 227 may be co-axially aligned along a hinge axis H2-H2. A pin 230 may be disposed within lumens 217b, 227b of hinge protrusions 217, 227 to pivotably engage first endplate 210 to second endplate 220.


The expansion mechanism 240, 250 is designed to expand first endplate 210 and second endplate 220 away from each other as wedge 250 is translated towards second end 24 of implant 20 along rod assembly 240. Rod assembly 240 may be integrally formed, or may be formed of multiple components for, e.g., ease of manufacturing and/or assembly, like rod assembly 140 above. Rod assembly 240 may be secured to first and/or second endplates 210, 220 at a rod first end 245 such that a second rod end 246 may move relative to endplates 210, 220 as implant 20 is expanded or contracted (i.e., moved into an opened or closed configuration). In some embodiments, longitudinal axis E2-E2 of expansion mechanism 240, 250 may be aligned along mid-longitudinal axis L2-L2 of implant 20. In other embodiments, longitudinal axis E2-E2 of expansion mechanism 240, 250 may be offset from mid-longitudinal axis L2-L2 of implant 20, as depicted in FIG. 25, and/or may be angled obliquely to mid-longitudinal axis L2-L2, as depicted in FIG. 26. As described above for implant 10, second end 246 of rod assembly 240 may comprise an interface 244 configured to be operably engaged by a drive shaft (not shown) to rotate rod assembly 240. Rod interface 244 may comprise a drive receptacle configured to cooperate with an implant engaging end of the drive shaft. The drive connection between the drive shaft and rod interface 244 may comprise a variety of drive interfaces including but not limited to: multi-lobular drives; hexalobular drives; cross or Phillips head drives; straight or “flat head” drives; square or other polygonal drives; and/or combinations thereof. In other embodiments, first end 245 of rod assembly 240 may further comprise an interface configured to be operably engaged by a drive shaft to rotate rod assembly 240. In this way, implants of the present disclosure may be expanded from both an anterior/oblique and posterior approach, as depicted in FIGS. 25 and 26.


In some embodiments, upper surface 258 and lower surface 256 of wedge 250 may be ramped or wedge-shaped and suitable for urging a complementary ramped or contoured surface on the inside of endplates 210, 220 so as to gradually move endplates 210, 220 away from each other as wedge 250 is advanced along the rod assembly 240 towards second end 24 of implant 20. In some embodiments, various designs may be used to optimize the interaction of wedge 250 with endplates 210, 220. Such configurations may include, but are not limited to: sequential ramps or tapered surfaces with varying angles; shallow angle sequential ramps or tapered surfaces leading into higher angle sequential ramps or tapered surfaces, as well as other opening mechanisms (such as a lateral post and channel system). As shown in FIGS. 21 and 23, inner surfaces 216, 226 of endplates 210, 220 may comprise guidewalls 216a, 226a with lateral channels 216c, 226c disposed therein to engage lateral posts 255a extending from wedge 250. The mechanism provided by posts 255a and channels 216c, 226c may also aid in making the implant 20 expansion substantially reversible. For example, in the depicted embodiment, when wedge 250 is moved towards second end 24 of implant 20, posts 255a are moved in a first direction in channels 216c, 226c to expand first endplate 210 and second endplate 220 away from each other (which may result in implant 20 opening to the expanded configuration shown generally in FIG. 15), and when wedge 250 is moved towards first end 22 of implant 20, posts 255a are moved in a second direction in channels 216c, 226c to contract first endplate 210 and second endplate 220 towards each other (which may result in implant 20 returning to the closed or unexpanded configuration shown generally in FIG. 14). This reversible feature, combined with the threaded interaction between rod assembly 240 and wedge 250 renders implant 20 capable of being incrementally expanded or contracted through a substantially infinite adjustable range of motion (bounded only by the length of channels 216c, 226c). The design of the expansion mechanism, including the length and orientation of channels 216c, 226c, may be adjusted to determine the amount of lordotic expansion. In some embodiments, implant 20 provides 12 degrees of lordotic correction when in a collapsed/closed state and is capable of up to 32 degrees, 60 degrees, or more of lordotic or hyperlordotic expansion as wedge 250 is moved towards second end 24 of implant 20.


In the depicted embodiment, second endplate 220 may comprise apertures 229 through which one or more screws 270 may be disposed to secure endplate 220 within an intervertebral space. Screws 270 may comprise a threaded outer surface 271 that engages with the inner surface of aperture 229, which may also be threaded. The engagement between threaded outer surface 271 and inner surface of aperture 229 may be via pitch lock, major/minor lock, or any other thread/pitch interface.


In some embodiments, second end 224 of second endplate 220 of implant 20 comprises inserter apertures 224b to engage with an insertion instrument 50 to form an expandable spinal implant system. As shown in FIGS. 24A-C, the number and arrangement of inserter apertures 224b allows the insertion instrument 50 to be attached to implant 20 in multiple orientations. This provides user flexibility to place implant 20 within intervertebral space with first endplate 210 superior to second endplate 220 or with first endplate 210 inferior to second endplate 220 such that screws 270 may be placed in either the cephalad or caudad vertebral bodies. In one embodiment, the inserter apertures are offset from mid-longitudinal axis which allows the inserter to be attached at a 15 degree angle allowing the device to be placed from an oblique approach.



FIGS. 27-36 show various configurations of an implant 30 embodiment according to the present disclosure. Implant 30 is generally similar in construction to implants 10, 20 described above and comprises a first endplate 310 and second endplate 320 operably engaged to one another via a hinge mechanism along the first end 32, and an expansion mechanism comprising a rod assembly 340 and a wedge 350 disposed between first and second endplates 310, 320. First endplate 310 includes a first end 312, a second end 314, opposing side surfaces 315 extending from the first end 312 of the first endplate to a portion of the second end 314 of the first endplate, and with the first endplate being therebetween, an inner surface 316, and an outer surface 318. Second endplate 320 includes a first end 322, a second end 324, opposing side surfaces 325 extending from the first end 322 of the second endplate to a portion of the second end 324 of the second endplate, and with the second endplate being therebetween, an inner surface 326, and an outer surface 328. In one embodiment, the endplates 310, 320 includes projections 311, 321 configured to engage a surface of the endplate of the adjacent vertebral body (not shown). Projections 311, 321 may comprise various anti-migration, anti-expulsion and/or osseointegration features including, but not limited to: ridges, teeth, pores, and coatings (including but not limited to porous titanium coatings such as those provided on Capstone PTC™ implants available from Medtronic). Endplates 310, 320 may further comprise at least one opening 313, 323 defined therein, configured to allow bone growth materials to be packed, placed, or loaded into implant 30.


The endplates 310, 320 may be operably engaged via a hinge mechanism located near or on the first ends 312 and 322. For example, first end 312 of first endplate 310 may comprise first and second hinge protrusions 317 extending along at least a portion of the length of first end 312 perpendicular to mid-longitudinal axis L3-L3. In some embodiments, first and second hinge protrusions are cylindrical and extend from lateral side surfaces 315 towards the mid-longitudinal axis L3-L3, and further comprise lumen 317b extending therethrough. First end 322 of second endplate 320 may also comprise a hinge protrusion 327. In some embodiments, hinge protrusion 327 is cylindrical and extends laterally along first end 322, and further comprises a lumen 327b extending therethrough. Lumens 317b, 327b of hinge protrusions 317, 327 may be co-axially aligned along a hinge axis H3-H3. A pin 330 may be disposed within lumens 217b, 327b of hinge protrusions 317, 327 to pivotably engage first endplate 310 to second endplate 320.


The expansion mechanism 340, 350 is designed to expand first endplate 310 and second endplate 320 away from each other as wedge 350 is translated along rod assembly 340 towards second end 34 of implant 30. Rod assembly 340 may be integrally formed, or may be formed of multiple components for, e.g., ease of manufacturing and/or assembly, like rod assembly 140 above. Rod assembly 340 may be secured to first and/or second endplates 310, 320 at a first end 345 such that the second end 346 may move relative to endplates 310, 320 as implant 30 is expanded or contracted. In some embodiments, the longitudinal axis E3-E3 of expansion mechanism 340, 350 may be angled obliquely to mid-longitudinal axis L3-L3 at an angle θ, as depicted in FIG. 36. The shown device is angled at 15 degrees to optimize access for an oblique approach. As depicted in FIGS. 32, 34 and 35, first endplate 310, second endplate 320, and wedge 350 are designed with compound surface angles to ensure proper contact between wedge 350 and endplates 310, 320 throughout the range of translation


As described above for implants 10, 20, the second end 346 of rod assembly 340 may comprise an interface 344 configured to be operably engaged by a drive shaft (not shown) to rotate the rod assembly 340. Rod interface 344 may comprise a drive receptacle configured to cooperate with an implant engaging end of the drive shaft. The drive connection between the drive shaft and rod interface 344 may comprise a variety of drive interfaces including but not limited to: multi-lobular drives; hexalobular drives; cross or Phillips head drives; straight or “flat head” drives; square or other polygonal drives; and/or combinations thereof. In other embodiments, first end 345 of rod assembly 340 may further comprise an interface configured to be operably engaged by a drive shaft to rotate rod assembly 340. In this way, implants of the present disclosure may be expanded from both an anterior/oblique and posterior approach, as depicted in FIG. 36.


In some embodiments, upper surface 358 and lower surface 356 of wedge 350 may be ramped or wedge-shaped and suitable for urging a complementary ramped or contoured surface on the inner surfaces 316, 326 of endplates 310, 320 so as to gradually move the endplates 310, 320 away from each other as wedge 350 is advanced along rod assembly 340. In some embodiments, various designs may be used to optimize the interaction of the wedge 350 with the endplates 210, 220. For example, as depicted in FIG. 35, one lateral side 355 of wedge 350 may be taller than opposing lateral side 355 of wedge 350 such that upper surface 358 and lower surface 356 may be angled. Inner surfaces 316, 326 of endplates 310, 320 are angled in a complementary manner in order to ensure proper contact between wedge 350 and endplates 310, 320 as wedge 350 is translated along rod assembly 340 at an angle oblique to mid-longitudinal axis L3-L3 of implant 30. Other configurations may include, but are not limited to: sequential ramps or tapered surfaces with varying angles; shallow angle sequential ramps or tapered surfaces leading into higher angle sequential ramps or tapered surfaces, as well as other opening mechanisms (such as a lateral post and channel system). In some embodiments, inner surfaces 316, 326 of endplates 310, 320 may comprise guidewalls 316a, 326a with lateral channels 316c, 326c disposed therein to engage lateral posts 355a extending from wedge 350. The mechanism provided by posts 355a and channels 316c, 326c may also aid in making the implant 30 expansion substantially reversible. For example, in the depicted embodiment, when wedge 350 is moved towards second end 34 of implant 30, posts 355a are moved in a first direction in channels 316c, 326c to expand first endplate 310 and second endplate 320 away from each other (which may result in implant 30 opening to the expanded configuration shown generally in FIG. 28), and when wedge 350 is moved towards second end 32 of implant 30, posts 355a are moved in a second direction in channels 316c, 326c to contract the first endplate 310 and second endplate 320 towards each other (which may result in the implant 30 returning to the closed or unexpanded configuration shown generally in FIG. 27). This reversible feature, combined with the threaded interaction between rod assembly 340 and wedge 350 renders implant 30 capable of being incrementally expanded or contracted through a substantially infinite adjustable range of motion (bounded only by the length of the channels 316c, 326c). The design of the expansion mechanism, including the length and orientation of the channels 316c, 326c, may be adjusted to determine the amount of lordotic expansion. In some embodiments, implant 30 provides 12 degrees of lordotic correction when in a collapsed/closed state and is capable of up to 30 degrees, 60 degrees, or more of lordotic or hyperlordotic expansion as the wedge 350 is moved towards second end 34 of implant 30.


In some embodiments, endplate 320 may comprise one or more tabs 329 comprising an aperture 329a through which one or more screws 370 may be disposed to secure endplate 320 within an intervertebral space. Screws 370 may comprise a threaded outer surface 371 that engages with the inner surface of aperture 329a, which may also be threaded. The engagement between threaded outer surface 371 and the inner surface of aperture 329a may be via pitch lock, major/minor lock, or any other thread/pitch interface.


In some embodiments, second end 324 of second endplate 320 of implant 30 comprises inserter apertures 324b to engage with an insertion instrument (not shown) to form an expandable spinal implant system. The number and arrangement of inserter apertures 324b allows the insertion instrument to be attached to implant 30 in multiple orientations. This provides user flexibility to place implant 30 within intervertebral space with first endplate 310 superior to second endplate 320 or with first endplate 310 inferior to second endplate 320 such that the tab 329 may be used to secure second endplate 320 in either the cephalad or caudad vertebral bodies.


Spinal implant systems of the present disclosure can be employed with a surgical arthrodesis procedure, such as, for example, an interbody fusion for treatment of an applicable condition or injury of an affected section of a spinal column and adjacent areas within a body, such as, for example, intervertebral disc space between adjacent vertebrae, and with additional surgical procedures and methods. In some embodiments, spinal implant systems can include an intervertebral implant that can be inserted with intervertebral disc space to space apart articular joint surfaces, provide support and maximize stabilization of vertebrae. In some embodiments, spinal implant systems may be employed with one or a plurality of vertebra.


A medical practitioner obtains access to a surgical site including vertebrae such as through incision and retraction of tissues. Spinal implant systems of the present disclosure can be used in any existing surgical method or technique including open surgery, mini-open surgery, minimally invasive surgery and percutaneous surgical implantation, whereby vertebrae are accessed through a mini-incision, retractor, tube or sleeve that provides a protected passageway to the area, including, for example, an expandable retractor wherein the sleeve is formed from multiple portions that may be moved apart or together and may be inserted with the portions closed or together and then expanded to allow for insertion of implants of larger size than the closed cross section of the unexpanded retractor portions. In one embodiment, the components of the spinal implant system are delivered through a surgical pathway to the surgical site along a surgical approach into intervertebral disc space between vertebrae. Various surgical approaches and pathways may be used. For example, FIGS. 37-39 depict various views of a typical anterior lumbar interbody fusion (ALIF) approach using a spinal implant of the present disclosure. Unilateral approaches such as a transforaminal lumbar interbody fusion (TLIF) approach may also be used to place the implant in a substantially oblique position relative to the vertebrae. Multilateral approaches such as those disclosed in U.S. Pat. No. 9,730,684, incorporated herein by reference in its entirety, may also be used with spinal implant systems of the present disclosure.


As will be appreciated by one of skill in the art, a preparation instrument (not shown) may be employed to remove disc tissue, fluids, adjacent tissues and/or bone, and scrape and/or remove tissue from endplate surfaces of a first vertebra and/or endplate surface of a second vertebra in preparation for or as part of the procedures utilizing a system of the present disclosure. In some embodiments, the size of implant 10, 20, 30 is selected after trialing using trialing instruments (not shown) that may approximate the size and configuration of the implants 10, 20, 30. In some embodiments, such trials may be fixed in size and/or be fitted with expansion mechanisms similar to the various implant 10, 20, 30 embodiments described herein. In some embodiments, implant 10 may be visualized by fluoroscopy and oriented before introduction into intervertebral disc space. Furthermore, the insertion instruments 40, 50 and implants 10, 20, 30 may be fitted with fiducial markers to enable image guided surgical navigation to be used prior to and/or during a procedure.


Components of a spinal implant system of the present disclosure including implant 10, 20, 30 can be delivered or implanted as a pre-assembled device or can be assembled in situ. Components of spinal implant system including implant 10, 20, 30 may be expanded, contracted, completely or partially revised, removed or replaced in situ. In some embodiments, one or all of the components of spinal implant system 10, 20, 30 can be delivered to the surgical site via mechanical manipulation and/or a free hand technique.


In some embodiments, the spinal implant system includes an agent, including but not limited to the bone growth promoting materials described herein, which may be disposed, packed, coated or layered within, on or about the components and/or surfaces of the spinal implant system. In some embodiments the bone growth promoting materials may be pre-packed in the interior of the implant, and/or may be packed during or after implantation of the implant via a tube, cannula, syringe or a combination of these or other access instruments and may be further tamped into the implant before, during or after implantation. In some embodiments, the agent may include bone growth promoting material to enhance fixation of implants 10, 20, 30 with bony structures. In some embodiments, the agent may include one or a plurality of therapeutic agents and/or pharmacological agents for release, including sustained release, to treat, for example, pain, inflammation and degeneration.


In one embodiment, implants 10, 20, 30 may include fastening elements, which may include locking structure, configured for fixation with vertebrae to secure joint surfaces and provide complementary stabilization and immobilization to a vertebral region. In some embodiments, locking structure may include fastening elements, such as, for example, rods, plates, clips, hooks, adhesives and/or flanges. In some embodiments, the components of spinal implant system 20, 30 can be used with screws to enhance fixation. The components of the spinal implant system can be made of radiolucent materials such as polymers. Radiopaque markers may be included for identification under x-ray, fluoroscopy, CT or other imaging techniques. The insertion instruments 40, 50 may be radiolucent and may optionally include markers added at the tip and/or along the length of one or both of insertion instruments 40, 50 and the tube to permit them to be seen on fluoroscopy/x-ray while advancing into the patient. If the implants 10, 20, 30 includes radiolucent markers placed near the end this may permit visualization of the proximity of the tip of the tube moving toward the second ends 14, 24, 34 of implants 10, 20, 30.


In some embodiments, the use of microsurgical, minimally-invasive and image guided technologies may be employed to access, view and repair spinal deterioration or damage, with the aid of spinal implant system. Upon completion of the procedure, the non-implanted components, surgical instruments and assemblies of spinal implant system may be removed and the incision is closed. In some embodiments, the various instruments disclosed may be provided with fiducial markers or other elements suitable for use with surgical navigation systems (including, but not limited to the STEALTHSTATION® Navigation system available from Medtronic), such that a surgeon may view a projected trajectory or insertion pathway of the implants 10, 20, 30 relative to a patient's anatomy in real time and/or in near-real time.


It will be understood that the various independent components of the expandable spinal implants 10, 20, 30, and insertion instruments 40, 50 described herein may be combined in different ways according to various embodiments.


It will be understood that various modifications may be made to the embodiments disclosed herein. Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as exemplary only, with the true scope and spirit of the invention being indicated by the following claims.

Claims
  • 1. An expandable spinal implant deployable between a contracted position and an expanded position, comprising: a first endplate, the first endplate including an outer surface configured to engage a first vertebra and an inner surface, a first endplate first end, a first endplate second end, a first endplate first lateral surface extending between the first endplate first end and the first endplate second end, an opposing first endplate second lateral surface extending between the first endplate first end and the first endplate second end;a second endplate, the second endplate including an outer surface configured to engage a second vertebra and an inner surface, a second endplate first end, a second endplate second end, a second endplate first lateral surface extending between the second endplate first end and the second endplate second end, and an opposing second endplate second lateral surface extending between the second endplate first end and the second endplate second end;an expansion mechanism disposed between the first endplate and the second endplate, the expansion mechanism being configured to angularly expand the first endplate relative to the second endplate such that the first endplate second end pivots away from the second endplate second end, the expansion mechanism including:a wedge disposed between the first endplate and the second endplate, the wedge including an upper surface, a lower surface, a wedge first end, a wedge second end, a wedge first lateral surface extending between the wedge first end and the wedge second end, and an opposing wedge second lateral surface extending between the wedge first end and the wedge second end, wherein the wedge comprises a threaded wedge aperture between the wedge second end and the wedge first end; anda rod assembly, the rod assembly comprising a threaded rod extending in a longitudinal direction from a first end of the rod assembly adjacent the first endplate second end and the second endplate second end to a second end of the rod assembly adjacent the first endplate first end and the second endplate first end, the second end of the rod assembly being pivotally coupled to the first endplate first end and the second endplate first end, the threaded rod being disposed within the threaded wedge aperture such that rotation of the threaded rod linearly translates the wedge along the longitudinal direction of the threaded rod,wherein, in a first mode of operation, translation of the wedge along the threaded rod in a first direction expands the first endplate second end away from the second endplate second end thereby increasing an angle of inclination between the first endplate outer surface and the second endplate outer surface,wherein, in a second mode of operation, translation of the wedge along the threaded rod in a second direction, opposite the first direction, contracts the first endplate second end towards the second endplate second end thereby decreasing the angle of inclination between the first endplate outer surface and the second endplate outer surface, andwherein, in a plan view, the longitudinal direction of the threaded rod is oriented at an oblique angle with respect to a mid-longitudinal axis of the expandable spinal implant extending along a centerline of the expandable spinal implant.
  • 2. The expandable spinal implant of claim 1, wherein the first direction is towards the first and second endplate second ends.
  • 3. The expandable spinal implant of claim 1, wherein the upper surface of the wedge is inclined with respect to the longitudinal direction.
  • 4. The expandable spinal implant of claim 3, wherein the lower surface of the wedge is inclined with respect to the longitudinal direction.
  • 5. The expandable spinal implant of claim 4, wherein the inner surface of the first endplate comprises at least one ramp that directly contacts the upper surface of the wedge in the first mode of operation and the inner surface of the second endplate comprises at least one ramp that directly contacts the lower surface of the wedge in the first mode of operation.
  • 6. The expandable spinal implant of claim 3, wherein the inner surface of the first endplate comprises at least one ramp that directly contacts the upper surface of the wedge in the first mode of operation.
  • 7. The expandable spinal implant of claim 1, wherein the inner surface of the first endplate comprises a first guidewall and a second guidewall disposed on opposite sides of the longitudinal direction.
  • 8. The expandable spinal implant of claim 7, wherein: the first guidewall comprises a first channel and the second guidewall comprises a second channel,the wedge first lateral surface comprises a first lateral post and the wedge second lateral surface comprises a second lateral post, andthe first lateral post is disposed within the first channel and the second lateral post is disposed within the second channel.
  • 9. The expandable spinal implant of claim 8, wherein the inner surface of the second endplate comprises a third guidewall and a fourth guidewall disposed on the opposite sides of the longitudinal direction.
  • 10. The expandable spinal implant of claim 9, wherein: the third guidewall comprises a third channel and the fourth guidewall comprises a fourth channel,the wedge first lateral surface comprises a third lateral post and the wedge second lateral surface comprises a fourth lateral post, andthe third lateral post is disposed within the third channel and the fourth lateral post is disposed within the fourth channel.
  • 11. The expandable spinal implant of claim 1, wherein the angle of inclination between the first endplate outer surface and the second endplate outer surface is continuously adjustable between about 0 degrees and about 60 degrees.
  • 12. The expandable spinal implant of claim 1, wherein the second end of the rod assembly is coupled to a hinge pin disposed between the first endplate and the second endplate.
  • 13. The expandable spinal implant of claim 1, wherein the first endplate first end further comprises at least one protrusion comprising a lumen therethrough extending laterally along the first endplate first end;the second endplate first end further comprises at least one protrusion comprising a lumen therethrough extending laterally along the second endplate first end; andwherein the lumen through the at least one protrusion on the first endplate first end is co-axially aligned with the lumen through the at least one protrusion on the second endplate first end, and wherein a rod is disposed through the lumens to pivotably engage the first endplate first end with the second endplate first end.
  • 14. The expandable spinal implant of claim 1, further comprising a tab extending in a direction that is substantially perpendicular to the outer surface of the second endplate.
  • 15. The expandable spinal implant of claim 14, wherein: the tab comprises at least one aperture configured to receive a bone screw configured to secure the tab to a side surface of the second vertebra, andthe tab is configured to abut the side surface of the second vertebra.
  • 16. The expandable spinal implant of claim 1, wherein, in the plan view, the oblique angle of the longitudinal direction of the threaded rod with respect to the mid-longitudinal axis of the expandable spinal implant is fifteen degrees.
  • 17. An expandable spinal implant deployable between a contracted position and an expanded position, comprising: a first endplate, the first endplate including a first outer surface configured to engage a first vertebra and a first inner surface opposite the first outer surface, a first lateral surface and a second lateral surface opposite the first lateral surface, wherein the first endplate extends in a proximal-to-distal direction from a first proximal end to a first distal end opposite the first proximal end;a second endplate, the second endplate including a second outer surface configured to engage a second vertebra and a second inner surface opposite the second outer surface, a third lateral surface and a fourth lateral surface opposite the third lateral surface, wherein the second endplate extends in a second proximal-to-distal direction from a second proximal end to a second distal end opposite the second proximal end;an expansion mechanism disposed between the first endplate and the second endplate, the expansion mechanism being configured to angularly expand the first endplate relative to the second endplate such that the first proximal end away from the second proximal end, the expansion mechanism including:a wedge disposed between the first endplate and the second endplate, the wedge including an upper surface, a lower surface, a wedge first end, a wedge second end, a wedge first lateral surface extending between the wedge first end and the wedge second end, and an opposing wedge second lateral surface extending between the wedge first end and the wedge second end, wherein the wedge comprises a threaded wedge aperture between the wedge second end and the wedge first end; anda rod assembly, the rod assembly comprising a threaded rod extending in a longitudinal direction from a first end of the rod assembly to a second end of the rod assembly, the first end of the rod assembly being pivotally coupled to the first distal end and the second distal end, and the second end of the rod assembly comprising a rod interface, the threaded rod being disposed within the threaded wedge aperture such that rotation of the threaded rod linearly translates the wedge in the longitudinal direction,wherein, in a first mode of operation, translation of the wedge along the threaded rod in a first direction expands the first proximal end away from the second proximal end thereby increasing an angle of inclination between the first outer surface and the second outer surface,wherein, in a second mode of operation, translation of the wedge along the threaded rod in a second direction, opposite the first direction, contracts the first proximal end towards the second proximal end thereby decreasing the angle of inclination between the first outer surface and the second outer surface, andwherein, in a plan view, the longitudinal direction of the threaded rod is oriented at an oblique angle with respect to a mid-longitudinal axis of the expandable spinal implant extending along a centerline of the expandable spinal implant.
  • 18. The expandable spinal implant of claim 17, wherein, in the plan view, the oblique angle of the longitudinal direction of the threaded rod with respect to the mid-longitudinal axis of the expandable spinal implant is fifteen degrees.
CROSS-REFERENCE TO RELATED U.S. PATENT APPLICATION

This Application is a continuation of U.S. application Ser. No. 16/282,654 (now U.S. Pat. No. 11,020,239), entitled “EXPANDABLE SPINAL IMPLANT SYSTEM AND METHOD OF USING SAME”, filed Feb. 22, 2019, which claims benefit to U.S. Provisional Patent Application Ser. No. U.S. 62/633,952, entitled “EXPANDABLE SPINAL IMPLANT SYSTEM AND METHOD OF USING SAME”, filed Feb. 22, 2018. The entire disclosure of each is incorporated herein by reference in its entirety.

US Referenced Citations (966)
Number Name Date Kind
1677337 Grove Jul 1928 A
3847154 Nordin Nov 1974 A
4401112 Rezaian Aug 1983 A
4553273 Wu Nov 1985 A
4636217 Ogilvie et al. Jan 1987 A
4716894 Lazzeri et al. Jan 1988 A
4759769 Hedman et al. Jul 1988 A
5059193 Kuslich Oct 1991 A
5171278 Pisharodi Dec 1992 A
5228811 Potter Jul 1993 A
5284483 Johnson et al. Feb 1994 A
5336223 Rogers Aug 1994 A
5390683 Pisharodi Feb 1995 A
5522899 Michelson Jun 1996 A
5554191 Lahille et al. Sep 1996 A
5575790 Chen et al. Nov 1996 A
5609635 Michelson Mar 1997 A
5653762 Pisharodi Aug 1997 A
5653763 Errico Aug 1997 A
5658336 Pisharodi Aug 1997 A
5665122 Kambin Sep 1997 A
5693100 Pisharodi Dec 1997 A
5697977 Pisharodi Dec 1997 A
5702391 Lin Dec 1997 A
5702453 Rabbe et al. Dec 1997 A
5702455 Saggar Dec 1997 A
5797918 McGuire et al. Aug 1998 A
5800550 Sertich Sep 1998 A
5865848 Baker Feb 1999 A
5893890 Pisharodi Apr 1999 A
5931777 Sava Aug 1999 A
5941885 Jackson Aug 1999 A
5971987 Huxel et al. Oct 1999 A
5980522 Koros et al. Nov 1999 A
6045579 Hochshuler et al. Apr 2000 A
6074343 Nathanson et al. Jun 2000 A
6080193 Hochshuler et al. Jun 2000 A
6099531 Bonutti Aug 2000 A
6102949 Biedermann et al. Aug 2000 A
6102950 Vaccaro Aug 2000 A
6106557 Robioneck et al. Aug 2000 A
6113638 Williams et al. Sep 2000 A
6117174 Nolan Sep 2000 A
6132465 Ray et al. Oct 2000 A
6159211 Boriani et al. Dec 2000 A
6159244 Suddaby Dec 2000 A
6176882 Biedermann et al. Jan 2001 B1
6179873 Zientek Jan 2001 B1
6190414 Young et al. Feb 2001 B1
6193757 Foley et al. Feb 2001 B1
6217579 Koros Apr 2001 B1
6245108 Biscup Jun 2001 B1
6309421 Pisharodi Oct 2001 B1
6342074 Simpson Jan 2002 B1
6371989 Chauvin et al. Apr 2002 B1
6395031 Foley et al. May 2002 B1
6423063 Bonutti Jul 2002 B1
6432106 Fraser Aug 2002 B1
6436140 Liu et al. Aug 2002 B1
6443989 Jackson Sep 2002 B1
6443990 Aebi et al. Sep 2002 B1
6454806 Cohen et al. Sep 2002 B1
6454807 Jackson Sep 2002 B1
6461359 Tribus et al. Oct 2002 B1
6491724 Ferree Dec 2002 B1
6520991 Huene Feb 2003 B2
6520993 James et al. Feb 2003 B2
6524238 Velikaris et al. Feb 2003 B2
6527803 Crozet et al. Mar 2003 B1
6562074 Gerbec et al. May 2003 B2
6576016 Hochshuler et al. Jun 2003 B1
6623525 Ralph et al. Sep 2003 B2
6629998 Lin Oct 2003 B1
6635086 Lin Oct 2003 B2
6648917 Gerbec et al. Nov 2003 B2
6676703 Biscup Jan 2004 B2
6685742 Jackson Feb 2004 B1
6723126 Berry Apr 2004 B1
6770096 Bolger et al. Aug 2004 B2
6773460 Jackson Aug 2004 B2
6821298 Jackson Nov 2004 B1
6835206 Jackson Dec 2004 B2
6849093 Michelson Feb 2005 B2
6852129 Gerbec et al. Feb 2005 B2
6863673 Gerbec et al. Mar 2005 B2
6923814 Hildebrand et al. Aug 2005 B1
6926737 Jackson Aug 2005 B2
6953477 Berry Oct 2005 B2
6964687 Bernard et al. Nov 2005 B1
6974480 Messerli et al. Dec 2005 B2
6984234 Bray Jan 2006 B2
7112222 Fraser et al. Sep 2006 B2
7135043 Nakahara et al. Nov 2006 B2
7137997 Paul Nov 2006 B2
7172627 Fiere et al. Feb 2007 B2
7188626 Foley et al. Mar 2007 B2
7204853 Gordon et al. Apr 2007 B2
7232464 Mathieu et al. Jun 2007 B2
7238203 Bagga et al. Jul 2007 B2
7255700 Kaiser et al. Aug 2007 B2
7316532 Matthys-Mark Jan 2008 B2
7316714 Gordon et al. Jan 2008 B2
7407483 Perez-Cruet et al. Aug 2008 B2
7481766 Lee et al. Jan 2009 B2
7491168 Raymond et al. Feb 2009 B2
7537565 Bass May 2009 B2
7618456 Mathieu et al. Nov 2009 B2
7625394 Molz, IV et al. Dec 2009 B2
7635366 Abdou Dec 2009 B2
7637909 Lechot et al. Dec 2009 B2
7655046 Dryer et al. Feb 2010 B2
7678148 Peterman Mar 2010 B2
7703727 Selness Apr 2010 B2
7708778 Gordon et al. May 2010 B2
7708779 Edie et al. May 2010 B2
7727280 McLuen Jun 2010 B2
7753958 Gordon et al. Jul 2010 B2
7780594 Hutton Aug 2010 B2
7806932 Webb et al. Oct 2010 B2
7815682 Peterson et al. Oct 2010 B1
7819801 Miles et al. Oct 2010 B2
7824428 Mikkonen et al. Nov 2010 B2
7828849 Lim Nov 2010 B2
7846167 Garcia et al. Dec 2010 B2
7846207 Lechmann et al. Dec 2010 B2
7850731 Brittan et al. Dec 2010 B2
7850733 Baynham et al. Dec 2010 B2
7862616 Lechmann et al. Jan 2011 B2
7875076 Mathieu et al. Jan 2011 B2
7892173 Miles et al. Feb 2011 B2
7909869 Gordon et al. Mar 2011 B2
7914559 Carls et al. Mar 2011 B2
7967821 Sicvol et al. Jun 2011 B2
7981031 Frasier et al. Jul 2011 B2
8016836 Corrao et al. Sep 2011 B2
8062375 Glerum et al. Nov 2011 B2
8105382 Olmos et al. Jan 2012 B2
8118870 Gordon et al. Feb 2012 B2
8118871 Gordon et al. Feb 2012 B2
8123810 Gordon et al. Feb 2012 B2
8147550 Gordon et al. Apr 2012 B2
8172903 Gordon et al. May 2012 B2
8182539 Tyber et al. May 2012 B2
8257442 Edie et al. Sep 2012 B2
8262570 White et al. Sep 2012 B2
8262662 Beardsley et al. Sep 2012 B2
8262710 Freedman et al. Sep 2012 B2
8287597 Pimenta et al. Oct 2012 B1
8303498 Miles et al. Nov 2012 B2
8303658 Peterman Nov 2012 B2
8303663 Jimenez et al. Nov 2012 B2
8317866 Palmatier et al. Nov 2012 B2
8323185 Perez-Cruet et al. Dec 2012 B2
8328872 Duffield et al. Dec 2012 B2
8343048 Warren, Jr. Jan 2013 B2
8353826 Weiman Jan 2013 B2
8355780 Miles et al. Jan 2013 B2
8382842 Greenhalgh et al. Feb 2013 B2
8388527 Miles et al. Mar 2013 B2
8398713 Weiman Mar 2013 B2
8403990 Dryer et al. Mar 2013 B2
8419797 Biedermann et al. Apr 2013 B2
8425528 Berry et al. Apr 2013 B2
8435298 Weiman May 2013 B2
8480576 Sandhu Jul 2013 B2
8496706 Ragab et al. Jul 2013 B2
8500634 Miles et al. Aug 2013 B2
8506635 Palmatier et al. Aug 2013 B2
8517935 Marchek et al. Aug 2013 B2
8518120 Glerum et al. Aug 2013 B2
8535380 Greenhalgh Sep 2013 B2
8550994 Miles et al. Oct 2013 B2
8556808 Miles et al. Oct 2013 B2
8556979 Glerum et al. Oct 2013 B2
8579809 Parker Nov 2013 B2
8579898 Prandi et al. Nov 2013 B2
8579979 Edie et al. Nov 2013 B2
8579981 Lim et al. Nov 2013 B2
8602984 Raymond et al. Dec 2013 B2
8608785 Reed et al. Dec 2013 B2
8628576 Triplett et al. Jan 2014 B2
8628578 Miller et al. Jan 2014 B2
8632595 Weiman Jan 2014 B2
8641768 Duffield et al. Feb 2014 B2
8647386 Gordon et al. Feb 2014 B2
8663329 Ernst Mar 2014 B2
8668419 Hardt et al. Mar 2014 B2
8668715 Sandhu Mar 2014 B2
8679183 Glerum et al. Mar 2014 B2
8685095 Miller et al. Apr 2014 B2
8685098 Glerum et al. Apr 2014 B2
8696559 Miles et al. Apr 2014 B2
8709083 Duffield et al. Apr 2014 B2
8709085 Lechmann et al. Apr 2014 B2
8709086 Glerum Apr 2014 B2
8715285 Lewis et al. May 2014 B2
8715353 Bagga et al. May 2014 B2
8740983 Arnold et al. Jun 2014 B1
8753271 Miles et al. Jun 2014 B1
8753396 Hockett et al. Jun 2014 B1
8764649 Miles et al. Jul 2014 B2
8771360 Jimenez et al. Jul 2014 B2
8778025 Ragab et al. Jul 2014 B2
8778027 Medina Jul 2014 B2
8795366 Varela Aug 2014 B2
8808305 Kleiner Aug 2014 B2
8827902 Dietze, Jr. et al. Sep 2014 B2
8828085 Jensen Sep 2014 B1
8840668 Donahoe et al. Sep 2014 B1
8845731 Weiman Sep 2014 B2
8845732 Weiman Sep 2014 B2
8845734 Weiman Sep 2014 B2
8852252 Venturini et al. Oct 2014 B2
8852282 Farley et al. Oct 2014 B2
8864833 Glerum et al. Oct 2014 B2
8882813 Jones et al. Nov 2014 B2
8888853 Glerum et al. Nov 2014 B2
8894708 Thalgott et al. Nov 2014 B2
8894711 Varela Nov 2014 B2
8894712 Varela Nov 2014 B2
8906095 Christensen et al. Dec 2014 B2
8920500 Pimenta et al. Dec 2014 B1
8926704 Glerum et al. Jan 2015 B2
8936641 Cain Jan 2015 B2
8940049 Jimenez et al. Jan 2015 B1
8968363 Weiman et al. Mar 2015 B2
8986344 Sandhu Mar 2015 B2
8992425 Karpowicz et al. Mar 2015 B2
8992544 Sasing Mar 2015 B2
9005292 Melamed Apr 2015 B2
9005293 Moskowitz et al. Apr 2015 B2
9005295 Kueenzi et al. Apr 2015 B2
9017412 Wolters et al. Apr 2015 B2
9034045 Davenport et al. May 2015 B2
9050146 Woolley et al. Jun 2015 B2
9050194 Thibodeau Jun 2015 B2
9060877 Kleiner Jun 2015 B2
9072548 Matityahu Jul 2015 B2
9072563 Garcia et al. Jul 2015 B2
9084591 Reglos et al. Jul 2015 B2
9113854 Ellman Aug 2015 B2
9119730 Glerum et al. Sep 2015 B2
9125757 Weiman Sep 2015 B2
9132021 Mermuys et al. Sep 2015 B2
9138217 Smith et al. Sep 2015 B2
9138330 Hansell et al. Sep 2015 B2
9138331 Aferzon Sep 2015 B2
9149367 Davenport et al. Oct 2015 B2
9155628 Glerum et al. Oct 2015 B2
9155631 Seifert et al. Oct 2015 B2
9161841 Kana et al. Oct 2015 B2
9179903 Cianfrani et al. Nov 2015 B2
9179952 Biedermann et al. Nov 2015 B2
9186193 Kleiner et al. Nov 2015 B2
9186258 Davenport et al. Nov 2015 B2
9192482 Pimenta et al. Nov 2015 B1
9192483 Radcliffe et al. Nov 2015 B1
9198772 Weiman Dec 2015 B2
9204972 Weiman et al. Dec 2015 B2
9204974 Glerum et al. Dec 2015 B2
9211194 Bagga et al. Dec 2015 B2
9211196 Glerum et al. Dec 2015 B2
9216095 Glerum et al. Dec 2015 B2
9226836 Glerum Jan 2016 B2
9233007 Sungarian et al. Jan 2016 B2
9233009 Gray et al. Jan 2016 B2
9233010 Thalgott et al. Jan 2016 B2
9259327 Niemiec et al. Feb 2016 B2
9271846 Lim et al. Mar 2016 B2
9308099 Triplett et al. Apr 2016 B2
9320610 Alheidt et al. Apr 2016 B2
9351845 Pimenta et al. May 2016 B1
9351848 Glerum et al. May 2016 B2
9357909 Perez-Cruet et al. Jun 2016 B2
9358126 Glerum et al. Jun 2016 B2
9358127 Duffield et al. Jun 2016 B2
9358128 Glerum et al. Jun 2016 B2
9358129 Weiman Jun 2016 B2
9364341 Gowan Jun 2016 B2
9364343 Duffield et al. Jun 2016 B2
9370434 Weiman Jun 2016 B2
9370435 Walkenhorst et al. Jun 2016 B2
9381008 Thornburg Jul 2016 B2
9386916 Predick et al. Jul 2016 B2
9387092 Mermuys et al. Jul 2016 B2
9402673 Cormier et al. Aug 2016 B2
9402739 Weiman et al. Aug 2016 B2
9408596 Blain Aug 2016 B2
9408708 Greenhalgh Aug 2016 B2
9414828 Abidin et al. Aug 2016 B2
9414934 Cain Aug 2016 B2
9414937 Carlson et al. Aug 2016 B2
9421110 Masson et al. Aug 2016 B2
9427331 Arnin Aug 2016 B2
9445919 Palmatier et al. Sep 2016 B2
9452063 Glerum et al. Sep 2016 B2
9456903 Glerum et al. Oct 2016 B2
9456906 Gray et al. Oct 2016 B2
9468405 Miles et al. Oct 2016 B2
9474622 McLaughlin et al. Oct 2016 B2
9474625 Weiman Oct 2016 B2
9480573 Perloff et al. Nov 2016 B2
9480576 Pepper et al. Nov 2016 B2
9480579 Davenport et al. Nov 2016 B2
9486133 Lee et al. Nov 2016 B2
9486325 Davenport et al. Nov 2016 B2
9486327 Martynova et al. Nov 2016 B2
9486328 Jimenez et al. Nov 2016 B2
9492287 Glerum et al. Nov 2016 B2
9492288 Wagner Nov 2016 B2
9492289 Davenport et al. Nov 2016 B2
9498349 Patterson et al. Nov 2016 B2
9510954 Glerum et al. Dec 2016 B2
9517098 Anderson Dec 2016 B2
9522070 Flower et al. Dec 2016 B2
9526620 Slivka et al. Dec 2016 B2
9526625 Cain Dec 2016 B2
9532821 Moskowitz et al. Jan 2017 B2
9539103 McLaughlin et al. Jan 2017 B2
9539108 Glerum et al. Jan 2017 B2
9545320 Padovani et al. Jan 2017 B2
9549723 Hynes et al. Jan 2017 B2
9549824 McAfee Jan 2017 B2
9561116 Weiman et al. Feb 2017 B2
9566163 Suddaby et al. Feb 2017 B2
9566166 Parry et al. Feb 2017 B2
9566168 Glerum et al. Feb 2017 B2
9572560 Mast et al. Feb 2017 B2
9572677 Davenport et al. Feb 2017 B2
9572681 Mathieu et al. Feb 2017 B2
9579124 Gordon et al. Feb 2017 B2
9579139 Cormier et al. Feb 2017 B2
9579213 Bal et al. Feb 2017 B2
9585649 Blain et al. Mar 2017 B2
9585762 Suddaby et al. Mar 2017 B2
9585766 Robinson Mar 2017 B2
9585767 Robinson Mar 2017 B2
9592129 Slivka et al. Mar 2017 B2
9597195 Cain Mar 2017 B2
9603643 Reed et al. Mar 2017 B2
9603713 Moskowitz et al. Mar 2017 B2
9603717 Ibarra et al. Mar 2017 B2
9615818 Baudouin et al. Apr 2017 B2
9615936 Duffield et al. Apr 2017 B2
9622732 Martinelli et al. Apr 2017 B2
9622875 Moskowitz et al. Apr 2017 B2
9622876 Greenhalgh et al. Apr 2017 B1
9629729 Grimberg, Jr. et al. Apr 2017 B2
9636097 Bass May 2017 B2
9642720 Radcliffe et al. May 2017 B2
9649198 Wolters et al. May 2017 B2
9655746 Seifert May 2017 B2
9655747 Glerum et al. May 2017 B2
9662224 Weiman et al. May 2017 B2
9668784 Brumfield et al. Jun 2017 B2
9668876 Blain et al. Jun 2017 B2
9668879 Jimenez et al. Jun 2017 B2
9675465 Padovani et al. Jun 2017 B2
9675467 Duffield et al. Jun 2017 B2
9675468 Jensen Jun 2017 B1
9693871 Richerme et al. Jul 2017 B2
9700428 Niemiec et al. Jul 2017 B2
9707092 Davenport et al. Jul 2017 B2
9713536 Foley et al. Jul 2017 B2
9717601 Miller Aug 2017 B2
9730684 Beale et al. Aug 2017 B2
9730806 Capote Aug 2017 B2
9737288 Karpowicz et al. Aug 2017 B2
9750617 Lim et al. Sep 2017 B2
9750618 Daffinson et al. Sep 2017 B1
9757249 Radcliffe et al. Sep 2017 B2
9763722 Roybal Sep 2017 B2
9770343 Weiman Sep 2017 B2
9782265 Weiman et al. Oct 2017 B2
9788971 Stein Oct 2017 B1
9795370 O'Connell et al. Oct 2017 B2
9795371 Miles et al. Oct 2017 B2
9801733 Wolters et al. Oct 2017 B2
9801734 Stein Oct 2017 B1
9808352 Suddaby et al. Nov 2017 B2
9826966 Mast et al. Nov 2017 B2
9827024 Cormier et al. Nov 2017 B2
9827107 Arnin Nov 2017 B1
9833333 Duffield et al. Dec 2017 B2
9833336 Davenport et al. Dec 2017 B2
9839527 Robinson Dec 2017 B2
9839528 Weiman et al. Dec 2017 B2
9848993 Moskowitz et al. Dec 2017 B2
9848996 Faulhaber Dec 2017 B2
9855151 Weiman Jan 2018 B2
9867715 McLaughlin et al. Jan 2018 B2
9872779 Miller et al. Jan 2018 B2
9889019 Rogers et al. Feb 2018 B2
9907671 Fessler Mar 2018 B2
9907673 Weiman et al. Mar 2018 B2
9918709 Sandhu Mar 2018 B2
9924859 Lee et al. Mar 2018 B2
9924940 Moskowitz et al. Mar 2018 B2
9925062 Glerum et al. Mar 2018 B2
9925064 Duffield et al. Mar 2018 B2
9931223 Cain Apr 2018 B2
9937053 Melkent et al. Apr 2018 B2
9943342 Tanaka et al. Apr 2018 B2
9943418 Davenport et al. Apr 2018 B2
9949775 Reed et al. Apr 2018 B2
9949841 Glerum et al. Apr 2018 B2
9956087 Seifert et al. May 2018 B2
9962202 Anderson May 2018 B2
9962270 Alheidt et al. May 2018 B2
9962271 Glerum May 2018 B2
9962272 Daffinson May 2018 B1
9968461 Zappacosta et al. May 2018 B2
9968462 Weiman May 2018 B2
9974531 Miles et al. May 2018 B2
9974662 Hessler et al. May 2018 B2
9974664 Emerick et al. May 2018 B2
9980825 Nichols et al. May 2018 B2
9980826 Martynova et al. May 2018 B2
9987141 Duffield et al. Jun 2018 B2
9987143 Robinson et al. Jun 2018 B2
9987144 Seifert et al. Jun 2018 B2
9987146 Lentner et al. Jun 2018 B1
9993239 Karpowicz et al. Jun 2018 B2
9993350 Cain Jun 2018 B2
10004607 Weiman et al. Jun 2018 B2
10016282 Seifert et al. Jul 2018 B2
10016284 Moskowitz et al. Jul 2018 B2
10022239 Lentner et al. Jul 2018 B1
10028842 Gray et al. Jul 2018 B2
10034765 Blain et al. Jul 2018 B2
10034769 Baynham Jul 2018 B2
10034771 Capote et al. Jul 2018 B2
10034772 Glerum et al. Jul 2018 B2
10034773 McLaughlin et al. Jul 2018 B2
10039539 Friedrich et al. Aug 2018 B2
10039650 Lamborne et al. Aug 2018 B2
10052214 Jimenez et al. Aug 2018 B2
10058431 Tyber et al. Aug 2018 B2
10060469 Jimenez et al. Aug 2018 B2
10070852 Mast et al. Sep 2018 B2
10076320 Mast et al. Sep 2018 B2
10076423 Miller et al. Sep 2018 B2
10080666 Suddaby et al. Sep 2018 B2
10080669 Davenport et al. Sep 2018 B2
10085846 Grotz Oct 2018 B2
10085849 Weiman et al. Oct 2018 B2
10092417 Weiman et al. Oct 2018 B2
10098758 Matthews et al. Oct 2018 B2
10098759 Weiman Oct 2018 B2
10111755 Foley et al. Oct 2018 B2
10111758 Robinson Oct 2018 B2
10117754 Davenport et al. Nov 2018 B2
10117755 Emerick et al. Nov 2018 B2
10137002 Padovani et al. Nov 2018 B2
10137006 Dewey et al. Nov 2018 B2
10137007 Dewey et al. Nov 2018 B2
10137009 Weiman et al. Nov 2018 B2
10149671 Predick et al. Dec 2018 B2
10149710 Tanaka et al. Dec 2018 B2
10154781 Weiman Dec 2018 B2
10154912 Glerum Dec 2018 B2
10154914 Robinson Dec 2018 B2
10159584 Carnes et al. Dec 2018 B2
10166117 Daffinson et al. Jan 2019 B1
10172515 Lee et al. Jan 2019 B2
10172652 Woolley et al. Jan 2019 B2
10178987 Predick et al. Jan 2019 B2
10179053 Zappacosta et al. Jan 2019 B2
10182922 Nichols et al. Jan 2019 B2
10188527 Rogers et al. Jan 2019 B2
10195050 Palmatier et al. Feb 2019 B2
10201431 Slater et al. Feb 2019 B2
10213192 Capote Feb 2019 B2
10213193 Karpowicz et al. Feb 2019 B2
10219798 Capote Mar 2019 B2
10219913 Matthews et al. Mar 2019 B2
10219914 Faulhaber Mar 2019 B2
10219915 Stein Mar 2019 B1
10226356 Grotz Mar 2019 B2
10226359 Glerum et al. Mar 2019 B2
10238375 O'Connell et al. Mar 2019 B2
10238383 Moskowitz et al. Mar 2019 B2
10238503 Branch et al. Mar 2019 B2
10245015 Predick et al. Apr 2019 B2
10251643 Moskowitz et al. Apr 2019 B2
10265191 Lim et al. Apr 2019 B2
10278686 Baudouin et al. May 2019 B2
10278786 Friedrich et al. May 2019 B2
10278830 Walker et al. May 2019 B1
10278831 Sandul May 2019 B2
10278832 Nichols et al. May 2019 B2
10285680 Friedrich et al. May 2019 B2
10285819 Greenhalgh May 2019 B2
10285824 Robinson May 2019 B2
10292828 Greenhalgh May 2019 B2
10299777 Mast et al. May 2019 B2
10299934 Seifert et al. May 2019 B2
10299937 McAfee May 2019 B2
10307268 Moskowitz et al. Jun 2019 B2
10314622 Brumfield et al. Jun 2019 B2
10314719 Hessler et al. Jun 2019 B2
10322007 Masson et al. Jun 2019 B2
10322009 Aghayev et al. Jun 2019 B2
10327909 Baynham Jun 2019 B2
10327912 Suddaby Jun 2019 B1
10327917 Glerum et al. Jun 2019 B2
10342675 Alheidt Jul 2019 B2
10350085 Glerum et al. Jul 2019 B2
10357233 Miles et al. Jul 2019 B2
10363142 McClintock et al. Jul 2019 B2
10363144 Overes et al. Jul 2019 B2
10369004 Faulhaber Aug 2019 B2
10369008 Jimenez et al. Aug 2019 B2
10369010 Robinson et al. Aug 2019 B2
10369012 Fessler Aug 2019 B2
10376377 Seifert et al. Aug 2019 B2
10390962 Weiman Aug 2019 B2
10390964 Faulhaber Aug 2019 B2
10398563 Engstrom Sep 2019 B2
10398566 Olmos et al. Sep 2019 B2
10413419 Thibodeau Sep 2019 B2
10413422 Flower et al. Sep 2019 B2
10413423 Overes et al. Sep 2019 B2
10426450 Vogel et al. Oct 2019 B2
10426633 Moskowitz et al. Oct 2019 B2
10426634 Al-Jazaeri et al. Oct 2019 B1
10441430 Ludwig et al. Oct 2019 B2
10449056 Cain Oct 2019 B2
10456122 Koltz et al. Oct 2019 B2
10470894 Foley et al. Nov 2019 B2
10478319 Moskowitz et al. Nov 2019 B2
10492912 Gregersen et al. Dec 2019 B2
10492922 Mathieu et al. Dec 2019 B2
10492924 Stein et al. Dec 2019 B2
10500064 Robinson Dec 2019 B2
10512550 Bechtel et al. Dec 2019 B2
10517645 van der Pol Dec 2019 B2
10524924 Davenport et al. Jan 2020 B2
10531903 Daly et al. Jan 2020 B2
10537436 Maguire et al. Jan 2020 B2
10537438 Martynova et al. Jan 2020 B2
10555729 Cole et al. Feb 2020 B1
10561411 Cole et al. Feb 2020 B1
10575889 Roybal Mar 2020 B2
10575960 Duffield et al. Mar 2020 B2
10582959 Langer et al. Mar 2020 B2
10583015 Olmos et al. Mar 2020 B2
10603078 Simpson et al. Mar 2020 B2
10610376 Kuyler et al. Apr 2020 B2
10624757 Bost et al. Apr 2020 B2
10624758 Slivka et al. Apr 2020 B2
10624761 Davenport et al. Apr 2020 B2
10639163 Tyber et al. May 2020 B2
10639166 Weiman et al. May 2020 B2
10653458 Tanaka et al. May 2020 B2
10667925 Emerick et al. Jun 2020 B2
10667927 Lamborne et al. Jun 2020 B2
10675157 Zakelj et al. Jun 2020 B2
10682241 Glerum et al. Jun 2020 B2
10687963 Jimenez et al. Jun 2020 B2
10702393 Davenport et al. Jul 2020 B2
10709569 McLaughlin et al. Jul 2020 B2
10709571 Iott et al. Jul 2020 B2
10709572 Daffinson et al. Jul 2020 B2
10709575 Robinson Jul 2020 B2
10722377 Glerum et al. Jul 2020 B2
10722379 McLaughlin et al. Jul 2020 B2
10729561 Glerum Aug 2020 B2
10743858 Cole et al. Aug 2020 B1
10744002 Glerum et al. Aug 2020 B2
10758366 Daffinson et al. Sep 2020 B2
10758367 Weiman et al. Sep 2020 B2
10758369 Rogers et al. Sep 2020 B2
10765528 Weiman et al. Sep 2020 B2
10772737 Gray et al. Sep 2020 B2
10779955 Kuyler et al. Sep 2020 B2
10779957 Weiman et al. Sep 2020 B2
10786364 Davenport et al. Sep 2020 B2
10786369 Carnes et al. Sep 2020 B2
10799368 Glerum et al. Oct 2020 B2
10835387 Weiman et al. Nov 2020 B2
10842640 Weiman et al. Nov 2020 B2
10842644 Weiman et al. Nov 2020 B2
10856997 Cowan et al. Dec 2020 B2
10869769 Eisen et al. Dec 2020 B2
10874447 Tanaka et al. Dec 2020 B2
10874522 Weiman Dec 2020 B2
10874523 Weiman et al. Dec 2020 B2
10874524 Bjork Dec 2020 B2
10881524 Eisen et al. Jan 2021 B2
10881531 Berry Jan 2021 B2
10888431 Robinson Jan 2021 B1
10898344 Alheidt et al. Jan 2021 B2
10898346 Suddaby Jan 2021 B1
10925656 Cole et al. Feb 2021 B2
10925750 Zappacosta et al. Feb 2021 B2
10925752 Weiman Feb 2021 B2
10932920 Dewey et al. Mar 2021 B2
10940014 Greenhalgh Mar 2021 B2
10945858 Bechtel et al. Mar 2021 B2
10952866 Warren et al. Mar 2021 B2
10959855 Miller et al. Mar 2021 B2
10959856 Seifert et al. Mar 2021 B2
10973649 Weiman et al. Apr 2021 B2
10973650 Stein Apr 2021 B2
10980642 Glerum et al. Apr 2021 B2
10980644 Purcell et al. Apr 2021 B2
10993814 Wolters May 2021 B2
11007067 Masson et al. May 2021 B2
11013617 Weiman et al. May 2021 B2
11020238 Nichols et al. Jun 2021 B2
11020239 Miller et al. Jun 2021 B2
11026804 Jimenez et al. Jun 2021 B2
11026812 Daffinson et al. Jun 2021 B2
11033401 Shoshtaev Jun 2021 B2
11033402 Melkent et al. Jun 2021 B2
11033404 Faulhaber Jun 2021 B2
11039935 McAfee Jun 2021 B2
11045326 Seifert et al. Jun 2021 B2
11045327 Nichols et al. Jun 2021 B2
11051949 Walker et al. Jul 2021 B2
11051951 Robinson et al. Jul 2021 B2
11058469 Mahajan et al. Jul 2021 B2
11065127 Lentner et al. Jul 2021 B1
11065129 Sandul Jul 2021 B2
11065130 Branch et al. Jul 2021 B2
11076966 Faulhaber Aug 2021 B2
11083584 Lauf et al. Aug 2021 B2
11083595 Robinson Aug 2021 B2
11090167 Emerick et al. Aug 2021 B2
11096795 Padovani et al. Aug 2021 B2
11096797 Moskowitz et al. Aug 2021 B2
11103366 Glerum et al. Aug 2021 B2
RE48719 Suddaby et al. Sep 2021 E
11109980 Seifert et al. Sep 2021 B2
11116644 Marrocco et al. Sep 2021 B2
11123198 Black et al. Sep 2021 B2
11123200 Faulhaber Sep 2021 B2
11129731 Miller et al. Sep 2021 B2
11135071 Dewey et al. Oct 2021 B2
11147680 Tyber et al. Oct 2021 B2
11154404 Freedman et al. Oct 2021 B2
11160666 Burkhardt et al. Nov 2021 B2
11160669 Rogers et al. Nov 2021 B2
11166826 Huang Nov 2021 B2
11173044 Jones et al. Nov 2021 B1
11179234 Dacosta et al. Nov 2021 B2
11285014 Josse et al. Mar 2022 B1
11376134 Dewey et al. Jul 2022 B1
20020045943 Uk Apr 2002 A1
20020045945 Liu et al. Apr 2002 A1
20020055741 Schlapfer et al. May 2002 A1
20020116066 Chauvin et al. Aug 2002 A1
20020128713 Ferree Sep 2002 A1
20020151976 Foley et al. Oct 2002 A1
20020183762 Anderson et al. Dec 2002 A1
20030050701 Michelson Mar 2003 A1
20030130739 Gerbec et al. Jul 2003 A1
20030163132 Chin Aug 2003 A1
20040102778 Huebner et al. May 2004 A1
20040172134 Berry Sep 2004 A1
20040186570 Rapp Sep 2004 A1
20040193158 Lim et al. Sep 2004 A1
20040204713 Abdou Oct 2004 A1
20040249461 Ferree Dec 2004 A1
20040254643 Jackson Dec 2004 A1
20040254644 Taylor Dec 2004 A1
20050015149 Michelson Jan 2005 A1
20050033429 Kuo Feb 2005 A1
20050033439 Gordon et al. Feb 2005 A1
20050228398 Rathbun et al. Oct 2005 A1
20060122701 Kiester Jun 2006 A1
20060129244 Ensign Jun 2006 A1
20060260446 Chang Nov 2006 A1
20070173840 Huebner Jul 2007 A1
20070218750 Corrao et al. Sep 2007 A1
20070233150 Blain et al. Oct 2007 A1
20070270859 Companioni et al. Nov 2007 A1
20080058804 Lechot et al. Mar 2008 A1
20080132959 Mikkonen et al. Jun 2008 A1
20080140207 Olmos et al. Jun 2008 A1
20090024158 Viker Jan 2009 A1
20090292361 Lopez Nov 2009 A1
20100076440 Pamichev et al. Mar 2010 A1
20100082109 Greenhalgh et al. Apr 2010 A1
20100152853 Kirschman Jun 2010 A1
20100191336 Greenhalgh Jul 2010 A1
20100211176 Greenhalgh Aug 2010 A1
20100286777 Errico et al. Nov 2010 A1
20110118843 Mathieu et al. May 2011 A1
20110130838 Morgenstern Lopez Jun 2011 A1
20110153020 Abdelgany et al. Jun 2011 A1
20110218572 Lechmann et al. Sep 2011 A1
20120004732 Goel et al. Jan 2012 A1
20120095515 Hamilton Apr 2012 A1
20120101581 Mathieu et al. Apr 2012 A1
20120109142 Dayan May 2012 A1
20120109309 Mathieu et al. May 2012 A1
20120109310 Mathieu et al. May 2012 A1
20120109312 Mathieu et al. May 2012 A1
20120109313 Mathieu et al. May 2012 A1
20120123546 Medina May 2012 A1
20120143195 Sander Jun 2012 A1
20120150237 Combrowski Jun 2012 A1
20120197401 Duncan et al. Aug 2012 A1
20120209385 Aferzon Aug 2012 A1
20120215313 Saidha et al. Aug 2012 A1
20120215316 Mohr et al. Aug 2012 A1
20130158664 Palmatier et al. Jun 2013 A1
20130184823 Malberg Jul 2013 A1
20130190876 Drochner et al. Jul 2013 A1
20130211526 Alheidt et al. Aug 2013 A1
20130226191 Thoren et al. Aug 2013 A1
20130231747 Olmos et al. Sep 2013 A1
20130304136 Gourlaouen-Preissler et al. Nov 2013 A1
20130317312 Eastlack et al. Nov 2013 A1
20140018816 Fenn et al. Jan 2014 A1
20140107790 Combrowski Apr 2014 A1
20140114321 Davenport et al. Apr 2014 A1
20140114420 Robinson Apr 2014 A1
20140148904 Robinson May 2014 A1
20140163682 Iott et al. Jun 2014 A1
20140180419 Dmuschewsky Jun 2014 A1
20140194992 Medina Jul 2014 A1
20140249631 Weiman Sep 2014 A1
20140277471 Gray et al. Sep 2014 A1
20140277487 Davenport et al. Sep 2014 A1
20140277500 Logan et al. Sep 2014 A1
20140303674 Sasing Oct 2014 A1
20140364855 Stoll et al. Dec 2014 A1
20150223945 Weiman et al. Aug 2015 A1
20150230931 Greenhalgh Aug 2015 A1
20150238236 Sasing Aug 2015 A1
20150354635 McClymont et al. Dec 2015 A1
20160008924 Canourgues et al. Jan 2016 A1
20160022434 Robinson Jan 2016 A1
20160058571 McLaughlin et al. Mar 2016 A1
20160081681 Waugh et al. Mar 2016 A1
20160089247 Nichols et al. Mar 2016 A1
20160095710 Juszczyk et al. Apr 2016 A1
20160095718 Burkhardt Apr 2016 A1
20160199073 Nino et al. Jul 2016 A1
20160242930 Duffield et al. Aug 2016 A1
20160256291 Miller Sep 2016 A1
20160278830 Arrington Sep 2016 A1
20160296340 Gordon et al. Oct 2016 A1
20160310291 Greenhalgh Oct 2016 A1
20160345952 Kucharzyk et al. Dec 2016 A1
20160367377 Faulhaber Dec 2016 A1
20170010025 Mayershofer Jan 2017 A1
20170029635 Doll et al. Feb 2017 A1
20170035406 Abidin et al. Feb 2017 A1
20170049651 Lim et al. Feb 2017 A1
20170049653 Lim et al. Feb 2017 A1
20170095345 Davenport et al. Apr 2017 A1
20170100255 Hleihil et al. Apr 2017 A1
20170100257 Weiman et al. Apr 2017 A1
20170105844 Kuyler et al. Apr 2017 A1
20170112630 Kuyler et al. Apr 2017 A1
20170151065 Warren et al. Jun 2017 A1
20170156882 Rathbun et al. Jun 2017 A1
20170156884 Rathbun et al. Jun 2017 A1
20170189204 Riemhofer et al. Jul 2017 A1
20170202678 Duffield et al. Jul 2017 A1
20170215856 Martinelli et al. Aug 2017 A1
20170224502 Wolters et al. Aug 2017 A1
20170224504 Butler et al. Aug 2017 A1
20170231675 Combrowski Aug 2017 A1
20170246006 Carnes et al. Aug 2017 A1
20170290677 Olmos et al. Oct 2017 A1
20170296352 Richerme et al. Oct 2017 A1
20170367842 Predick Dec 2017 A1
20170367843 Eisen et al. Dec 2017 A1
20170367844 Eisen et al. Dec 2017 A1
20170367845 Eisen et al. Dec 2017 A1
20180000606 Hessler et al. Jan 2018 A1
20180030362 Kosler et al. Feb 2018 A1
20180031810 Hsu et al. Feb 2018 A1
20180036136 Duffield et al. Feb 2018 A1
20180036138 Robinson Feb 2018 A1
20180104066 Bae et al. Apr 2018 A1
20180116891 Beale et al. May 2018 A1
20180193160 Hsu et al. Jul 2018 A1
20180193164 Shoshtaev Jul 2018 A1
20180206999 Suddaby Jul 2018 A1
20180256356 Robinson et al. Sep 2018 A1
20180256359 Greenhalgh Sep 2018 A1
20180256360 Cain Sep 2018 A1
20180256362 Slivka et al. Sep 2018 A1
20180263784 Bechtel et al. Sep 2018 A1
20180280142 Schultz et al. Oct 2018 A1
20180303473 Spann et al. Oct 2018 A1
20180303621 Brotman et al. Oct 2018 A1
20180303625 Alheidt et al. Oct 2018 A1
20180311048 Glerum et al. Nov 2018 A1
20180318101 Engstrom Nov 2018 A1
20180318102 Seifert et al. Nov 2018 A1
20180325574 Bjork et al. Nov 2018 A1
20180338838 Cryder et al. Nov 2018 A1
20180338841 Miller et al. Nov 2018 A1
20180344307 Hynes et al. Dec 2018 A1
20180360616 Luu Dec 2018 A1
20190000640 Weiman Jan 2019 A1
20190000702 Lim et al. Jan 2019 A1
20190000707 Lim et al. Jan 2019 A1
20190020121 Paulotto et al. Jan 2019 A1
20190021716 Waugh et al. Jan 2019 A1
20190021873 Dmuschewsky Jan 2019 A1
20190046329 Padovani et al. Feb 2019 A1
20190046381 Lim et al. Feb 2019 A1
20190046383 Lim et al. Feb 2019 A1
20190060083 Weiman et al. Feb 2019 A1
20190082949 Weiman Mar 2019 A1
20190083081 Ortiz et al. Mar 2019 A1
20190091033 Dewey et al. Mar 2019 A1
20190105175 Zappacosta et al. Apr 2019 A1
20190125328 Blain May 2019 A1
20190133434 Lee et al. May 2019 A1
20190133645 Gordon et al. May 2019 A1
20190133779 McLaughlin et al. May 2019 A1
20190133780 Matthews et al. May 2019 A1
20190133784 Gunn et al. May 2019 A1
20190133788 Weiman et al. May 2019 A1
20190142480 Woolley et al. May 2019 A1
20190151115 Nichols et al. May 2019 A1
20190183656 Stein Jun 2019 A1
20190201209 Branch et al. Jul 2019 A1
20190201210 Besaw et al. Jul 2019 A1
20190209155 Mast et al. Jul 2019 A1
20190216453 Predick et al. Jul 2019 A1
20190231552 Sandul Aug 2019 A1
20190240039 Walker et al. Aug 2019 A1
20190240043 Greenhalgh Aug 2019 A1
20190247098 Brumfield et al. Aug 2019 A1
20190254650 Martinelli et al. Aug 2019 A1
20190254838 Miller et al. Aug 2019 A1
20190254839 Nichols et al. Aug 2019 A1
20190262009 Cheng Aug 2019 A1
20190262139 Wolters Aug 2019 A1
20190269521 Shoshtaev Sep 2019 A1
20190274670 O'Connell et al. Sep 2019 A1
20190274671 Lauf et al. Sep 2019 A1
20190274836 Eisen et al. Sep 2019 A1
20190282373 Alheidt Sep 2019 A1
20190290446 Masson et al. Sep 2019 A1
20190290447 Stein Sep 2019 A1
20190298416 Rezach Oct 2019 A1
20190298524 Lauf et al. Oct 2019 A1
20190298540 Aghayev et al. Oct 2019 A1
20190321022 Karpowicz et al. Oct 2019 A1
20190321190 Wagner et al. Oct 2019 A1
20190328539 Suh et al. Oct 2019 A1
20190328540 Seifert et al. Oct 2019 A1
20190329388 Erickson et al. Oct 2019 A1
20190336301 Engstrom Nov 2019 A1
20190336304 Burkhardt et al. Nov 2019 A1
20190350573 Vogel et al. Nov 2019 A1
20190358049 Faulhaber Nov 2019 A1
20190358050 Fessler Nov 2019 A1
20190358051 Flower et al. Nov 2019 A1
20190380840 Tyber et al. Dec 2019 A1
20190388232 Purcell et al. Dec 2019 A1
20200008951 McClintock et al. Jan 2020 A1
20200030114 Cain Jan 2020 A1
20200030116 Jimenez et al. Jan 2020 A1
20200038200 Foley et al. Feb 2020 A1
20200054461 Marrocco et al. Feb 2020 A1
20200060844 Mathieu et al. Feb 2020 A1
20200069316 DeSoutter et al. Mar 2020 A1
20200078190 Rogers et al. Mar 2020 A1
20200093526 Daly et al. Mar 2020 A1
20200093607 Davenport et al. Mar 2020 A1
20200093609 Shoshtaev Mar 2020 A1
20200100904 Stein et al. Apr 2020 A1
20200129306 Miller et al. Apr 2020 A1
20200129307 Hunziker et al. Apr 2020 A1
20200138591 Moskowitz et al. May 2020 A1
20200138593 Martynova et al. May 2020 A1
20200146840 Black et al. May 2020 A1
20200179120 Bielenstein et al. Jun 2020 A1
20200205993 Davenport et al. Jul 2020 A1
20200214754 Bowen et al. Jul 2020 A1
20200222202 Kuyler et al. Jul 2020 A1
20200229944 Suh et al. Jul 2020 A1
20200246159 Suh et al. Aug 2020 A1
20200246162 Schultz et al. Aug 2020 A1
20200261242 Bost et al. Aug 2020 A1
20200268524 Glerum et al. Aug 2020 A1
20200276028 Blain et al. Sep 2020 A1
20200281741 Grotz Sep 2020 A1
20200289287 Emerick et al. Sep 2020 A1
20200297507 Iott et al. Sep 2020 A1
20200330239 Davenport et al. Oct 2020 A1
20200330245 Glerum Oct 2020 A1
20200345511 Daffinson et al. Nov 2020 A1
20200352731 Berry Nov 2020 A1
20200352738 Berry Nov 2020 A1
20200360153 Weiman et al. Nov 2020 A1
20200375753 McLaughlin et al. Dec 2020 A1
20200375755 Cain Dec 2020 A1
20200383797 Predick et al. Dec 2020 A1
20200383799 Cain Dec 2020 A1
20200390565 Jimenez et al. Dec 2020 A1
20200397593 Davenport et al. Dec 2020 A1
20200405497 Olmos et al. Dec 2020 A1
20200405498 Gray et al. Dec 2020 A1
20200405499 Gerbec et al. Dec 2020 A1
20200405500 Cain Dec 2020 A1
20210007860 Glerum et al. Jan 2021 A1
20210015626 Suddaby Jan 2021 A1
20210030555 Weiman et al. Feb 2021 A1
20210030561 Gleason Feb 2021 A1
20210045891 Rogers et al. Feb 2021 A1
20210045892 Rogers et al. Feb 2021 A1
20210052395 Iott et al. Feb 2021 A1
20210068959 McLuen et al. Mar 2021 A1
20210068974 Cowan et al. Mar 2021 A1
20210068982 Carnes et al. Mar 2021 A1
20210077271 Sharabani Mar 2021 A1
20210077272 Eisen et al. Mar 2021 A1
20210085479 Weiman et al. Mar 2021 A1
20210093462 Lucasiewicz et al. Apr 2021 A1
20210106434 Alheidt et al. Apr 2021 A1
20210113349 Weiman et al. Apr 2021 A1
20210121299 Hyder Apr 2021 A1
20210121300 Weiman et al. Apr 2021 A1
20210137697 Weiman May 2021 A1
20210137699 Jang et al. May 2021 A1
20210137701 Miller et al. May 2021 A1
20210154811 Spreiter et al. May 2021 A1
20210161678 Dewey et al. Jun 2021 A1
20210177618 Branch et al. Jun 2021 A1
20210186706 Spitler et al. Jun 2021 A1
20210186709 Weiman et al. Jun 2021 A1
20210196470 Shoshtaev Jul 2021 A1
20210205092 Glerum et al. Jul 2021 A1
20210205094 Weiman et al. Jul 2021 A1
20210220145 Stein Jul 2021 A1
20210220147 Berry Jul 2021 A1
20210236298 Weiman et al. Aug 2021 A1
20210251770 Purcell et al. Aug 2021 A1
20210251776 Daffinson et al. Aug 2021 A1
20210259848 Kang et al. Aug 2021 A1
20210259849 Robinson et al. Aug 2021 A1
20210259850 Eisen et al. Aug 2021 A1
20210267767 Stein Sep 2021 A1
20210275317 Spetzger Sep 2021 A1
20210275318 Reimels Sep 2021 A1
20210275319 Reimels Sep 2021 A1
20210275321 Seifert et al. Sep 2021 A1
20210282938 Nichols et al. Sep 2021 A1
20210298915 Faulhaber Sep 2021 A1
20210298916 Melkent et al. Sep 2021 A1
20210307920 Walker et al. Oct 2021 A1
20210315705 Altarac et al. Oct 2021 A1
20210322179 Miller et al. Oct 2021 A1
20210322181 Predick Oct 2021 A1
20210322182 Faulhaber Oct 2021 A1
20210330472 Shoshtaev Oct 2021 A1
20210346174 Flint et al. Nov 2021 A1
20220015924 Freedman et al. Jan 2022 A1
20220047312 Seykora et al. Feb 2022 A1
20220133336 Tsai et al. May 2022 A1
20220133498 Josse et al. May 2022 A1
20220133499 Josse et al. May 2022 A1
20220387184 Josse et al. Dec 2022 A1
Foreign Referenced Citations (13)
Number Date Country
107 137 166 Sep 2017 CN
2954860 Dec 2015 EP
3031424 Jun 2016 EP
3 069 694 Sep 2016 EP
3213720 Sep 2017 EP
2781998 Feb 2000 FR
102192022 Dec 2020 KR
2006116850 Nov 2006 WO
2012139022 Oct 2012 WO
2015063721 May 2015 WO
2015198335 Dec 2015 WO
2016057940 Apr 2016 WO
2021055323 Mar 2021 WO
Non-Patent Literature Citations (11)
Entry
International Search Report and Written Opinion in Application No. PCT/US2022/016809 dated Jul. 27, 2022.
International Search Report and Written Opinion in Application No. PCT/US2022/027695 dated Jul. 27, 2022.
International Search Report, and Written Opinion for Application. No. PCT/US2019/019067, dated Jun. 3, 2019.
International Search Report and Written Opinion for Application No. PCT/US2019/019060, dated Jun. 5, 2019.
International Search Report and Written Opinion, PCT/IB2020/000932, dated Jul. 29, 2021.
International Search Report and Written Opinion, PCT/IB2020/000942, dated Aug. 10, 2021.
European Search Report, EP19756905, dated Oct. 18, 2021.
International Search Report and Written Opinion, PCT/US2022/030094, dated Sep. 16, 2022.
International Search Report and Written Opinion in Application No. PCT/US2022/016831 dated Sep. 29, 2022.
International Search Report and Written Opinion in Application No. PCT/US2022/027200 dated Aug. 19, 2022.
Chinese Office Action in Application No. 201980010758.4 dated Jun. 16, 2023.
Related Publications (1)
Number Date Country
20210322179 A1 Oct 2021 US
Provisional Applications (1)
Number Date Country
62633952 Feb 2018 US
Continuation in Parts (1)
Number Date Country
Parent 16282654 Feb 2019 US
Child 17246959 US